| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Predisposition to Disease | 303 | 2024 | 17904 | 5.970 |
Why?
|
| Polymorphism, Single Nucleotide | 315 | 2024 | 15936 | 5.580 |
Why?
|
| Polymorphism, Genetic | 107 | 2023 | 4243 | 5.430 |
Why?
|
| Breast Neoplasms | 270 | 2024 | 21019 | 5.310 |
Why?
|
| Genome-Wide Association Study | 197 | 2024 | 12690 | 4.010 |
Why?
|
| Case-Control Studies | 297 | 2024 | 22176 | 2.870 |
Why?
|
| Osteoarthritis, Knee | 27 | 2024 | 1234 | 2.760 |
Why?
|
| Colorectal Neoplasms | 74 | 2024 | 6938 | 2.410 |
Why?
|
| Genotype | 195 | 2023 | 12990 | 2.400 |
Why?
|
| Genetic Loci | 48 | 2022 | 2632 | 2.290 |
Why?
|
| State Medicine | 7 | 2023 | 216 | 2.250 |
Why?
|
| Risk Factors | 396 | 2024 | 74213 | 2.040 |
Why?
|
| Genetic Variation | 69 | 2022 | 6567 | 2.030 |
Why?
|
| Prostatic Neoplasms | 85 | 2023 | 11122 | 2.020 |
Why?
|
| Osteoarthritis | 10 | 2024 | 1063 | 1.920 |
Why?
|
| Public Health | 11 | 2023 | 2669 | 1.730 |
Why?
|
| Menarche | 17 | 2024 | 532 | 1.680 |
Why?
|
| Dietary Fats | 37 | 2022 | 1995 | 1.670 |
Why?
|
| Vitamin A | 31 | 2013 | 613 | 1.640 |
Why?
|
| Knee Joint | 13 | 2024 | 1676 | 1.600 |
Why?
|
| Humans | 941 | 2024 | 761596 | 1.530 |
Why?
|
| Postmenopause | 42 | 2018 | 2513 | 1.520 |
Why?
|
| Female | 706 | 2024 | 392705 | 1.490 |
Why?
|
| Adenoma | 23 | 2009 | 2163 | 1.460 |
Why?
|
| Skin Neoplasms | 41 | 2020 | 5821 | 1.450 |
Why?
|
| Vitamins | 28 | 2010 | 1635 | 1.430 |
Why?
|
| Genome, Human | 38 | 2019 | 4425 | 1.420 |
Why?
|
| Smoking | 66 | 2019 | 9053 | 1.410 |
Why?
|
| Alleles | 62 | 2021 | 6864 | 1.390 |
Why?
|
| Alcohol Drinking | 45 | 2022 | 4028 | 1.370 |
Why?
|
| Molecular Epidemiology | 7 | 2020 | 469 | 1.370 |
Why?
|
| Arthralgia | 2 | 2024 | 461 | 1.340 |
Why?
|
| Nurses | 59 | 2019 | 2478 | 1.340 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 16 | 2012 | 276 | 1.320 |
Why?
|
| Middle Aged | 457 | 2024 | 220921 | 1.310 |
Why?
|
| Premenopause | 34 | 2021 | 1039 | 1.300 |
Why?
|
| Folic Acid | 27 | 2015 | 1323 | 1.290 |
Why?
|
| Diet | 63 | 2021 | 8075 | 1.280 |
Why?
|
| Prospective Studies | 236 | 2024 | 54423 | 1.270 |
Why?
|
| Carotenoids | 15 | 2013 | 621 | 1.230 |
Why?
|
| Adult | 429 | 2024 | 221210 | 1.180 |
Why?
|
| Multifactorial Inheritance | 13 | 2024 | 1387 | 1.160 |
Why?
|
| Risk | 90 | 2021 | 9610 | 1.160 |
Why?
|
| Arylamine N-Acetyltransferase | 9 | 2023 | 87 | 1.160 |
Why?
|
| Contraceptives, Oral | 19 | 2017 | 554 | 1.150 |
Why?
|
| Linkage Disequilibrium | 48 | 2021 | 1998 | 1.130 |
Why?
|
| Education, Public Health Professional | 3 | 2015 | 27 | 1.080 |
Why?
|
| Pregnancy Complications, Infectious | 31 | 2010 | 2151 | 1.080 |
Why?
|
| Meat | 14 | 2013 | 584 | 1.070 |
Why?
|
| Carcinoma, Basal Cell | 22 | 2015 | 560 | 1.070 |
Why?
|
| Odds Ratio | 90 | 2021 | 9647 | 1.070 |
Why?
|
| Receptors, Progesterone | 17 | 2022 | 1129 | 1.060 |
Why?
|
| Menopause | 26 | 2022 | 1646 | 1.050 |
Why?
|
| Body Mass Index | 86 | 2024 | 12953 | 1.030 |
Why?
|
| Quantitative Trait Loci | 25 | 2024 | 2116 | 1.020 |
Why?
|
| Health Policy | 10 | 2020 | 2684 | 1.000 |
Why?
|
| Haplotypes | 41 | 2024 | 2713 | 0.980 |
Why?
|
| Cohort Studies | 184 | 2019 | 41495 | 0.970 |
Why?
|
| Gonadal Steroid Hormones | 13 | 2017 | 702 | 0.950 |
Why?
|
| Synovitis | 4 | 2017 | 217 | 0.950 |
Why?
|
| Aged | 260 | 2024 | 169310 | 0.920 |
Why?
|
| Medicine | 2 | 2023 | 942 | 0.910 |
Why?
|
| Diabetes Mellitus, Type 2 | 41 | 2024 | 12149 | 0.910 |
Why?
|
| Biological Specimen Banks | 3 | 2024 | 783 | 0.910 |
Why?
|
| Polychlorinated Biphenyls | 8 | 2007 | 236 | 0.910 |
Why?
|
| Tanzania | 45 | 2010 | 1390 | 0.880 |
Why?
|
| Receptors, Estrogen | 27 | 2022 | 2209 | 0.880 |
Why?
|
| Vitamin D | 18 | 2024 | 3303 | 0.880 |
Why?
|
| Endometrial Neoplasms | 20 | 2020 | 1366 | 0.870 |
Why?
|
| Chromosomes, Human, Pair 8 | 11 | 2016 | 453 | 0.870 |
Why?
|
| Body Height | 19 | 2016 | 1570 | 0.860 |
Why?
|
| DNA Repair | 14 | 2015 | 2046 | 0.850 |
Why?
|
| Aromatase | 7 | 2009 | 147 | 0.840 |
Why?
|
| Genetic Markers | 15 | 2015 | 2601 | 0.830 |
Why?
|
| DNA-Binding Proteins | 24 | 2015 | 9610 | 0.820 |
Why?
|
| Genetic Testing | 9 | 2023 | 3537 | 0.810 |
Why?
|
| Hypertension | 9 | 2022 | 8540 | 0.790 |
Why?
|
| Vitamin B 12 | 9 | 2021 | 524 | 0.790 |
Why?
|
| Gene Frequency | 37 | 2024 | 3606 | 0.790 |
Why?
|
| Hair Color | 9 | 2011 | 131 | 0.780 |
Why?
|
| Apolipoproteins E | 4 | 2024 | 1443 | 0.780 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 6 | 2001 | 86 | 0.780 |
Why?
|
| Chromosome Mapping | 28 | 2024 | 4615 | 0.780 |
Why?
|
| Infectious Disease Transmission, Vertical | 17 | 2009 | 1352 | 0.770 |
Why?
|
| Genomics | 10 | 2019 | 5821 | 0.770 |
Why?
|
| HIV Infections | 48 | 2010 | 17354 | 0.770 |
Why?
|
| Male | 325 | 2024 | 360846 | 0.770 |
Why?
|
| Quarantine | 2 | 2020 | 181 | 0.760 |
Why?
|
| Insulin-Like Growth Factor I | 17 | 2017 | 1935 | 0.760 |
Why?
|
| Life Style | 22 | 2021 | 3917 | 0.760 |
Why?
|
| HIV-1 | 28 | 2009 | 6863 | 0.750 |
Why?
|
| Neoplasms | 40 | 2019 | 22173 | 0.750 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 6 | 2002 | 61 | 0.740 |
Why?
|
| Receptors, Calcitriol | 9 | 2024 | 360 | 0.720 |
Why?
|
| Superoxide Dismutase | 4 | 2008 | 594 | 0.710 |
Why?
|
| Selenium | 13 | 2021 | 417 | 0.710 |
Why?
|
| Cartilage, Articular | 10 | 2024 | 1099 | 0.700 |
Why?
|
| Homosexuality, Female | 3 | 2020 | 171 | 0.690 |
Why?
|
| Sunburn | 7 | 2006 | 156 | 0.690 |
Why?
|
| Telomere | 9 | 2016 | 943 | 0.690 |
Why?
|
| Exercise | 18 | 2022 | 5890 | 0.690 |
Why?
|
| Germ-Line Mutation | 12 | 2021 | 1858 | 0.690 |
Why?
|
| Reproductive History | 3 | 2016 | 211 | 0.680 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 7 | 2009 | 244 | 0.680 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 12 | 2016 | 416 | 0.670 |
Why?
|
| Glutathione Transferase | 5 | 2024 | 565 | 0.660 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 2578 | 0.640 |
Why?
|
| Interferon Regulatory Factors | 3 | 2018 | 261 | 0.640 |
Why?
|
| Melanoma | 25 | 2020 | 5709 | 0.640 |
Why?
|
| Risk Assessment | 71 | 2024 | 23996 | 0.640 |
Why?
|
| Homocysteine | 7 | 2013 | 638 | 0.630 |
Why?
|
| Obesity | 44 | 2024 | 12947 | 0.620 |
Why?
|
| Incidence | 75 | 2024 | 21355 | 0.620 |
Why?
|
| Schools, Public Health | 2 | 2015 | 23 | 0.620 |
Why?
|
| Epidemiologic Studies | 5 | 2017 | 675 | 0.620 |
Why?
|
| Skin Pigmentation | 6 | 2011 | 277 | 0.600 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 3 | 2007 | 83 | 0.600 |
Why?
|
| Vegetables | 13 | 2009 | 1195 | 0.600 |
Why?
|
| Vitamin E | 16 | 2011 | 872 | 0.600 |
Why?
|
| Apolipoprotein E4 | 2 | 2022 | 709 | 0.590 |
Why?
|
| Mendelian Randomization Analysis | 13 | 2022 | 1007 | 0.590 |
Why?
|
| Low Back Pain | 4 | 2018 | 984 | 0.590 |
Why?
|
| Logistic Models | 58 | 2024 | 13255 | 0.590 |
Why?
|
| Multivariate Analysis | 61 | 2019 | 12059 | 0.580 |
Why?
|
| Endometriosis | 5 | 2006 | 870 | 0.580 |
Why?
|
| Osteoarthritis, Hip | 4 | 2024 | 409 | 0.570 |
Why?
|
| Carcinoma, Squamous Cell | 20 | 2014 | 4024 | 0.570 |
Why?
|
| Estrogens | 19 | 2010 | 1522 | 0.570 |
Why?
|
| United States | 139 | 2024 | 72340 | 0.570 |
Why?
|
| Population Surveillance | 9 | 2016 | 2598 | 0.550 |
Why?
|
| Chromosomes, Human, Pair 5 | 8 | 2016 | 386 | 0.550 |
Why?
|
| Europe | 29 | 2022 | 3420 | 0.540 |
Why?
|
| Fruit | 11 | 2009 | 1160 | 0.540 |
Why?
|
| Ovarian Neoplasms | 24 | 2019 | 4878 | 0.540 |
Why?
|
| Dietary Supplements | 24 | 2021 | 3415 | 0.530 |
Why?
|
| Micronutrients | 3 | 2021 | 382 | 0.530 |
Why?
|
| Follow-Up Studies | 75 | 2024 | 39106 | 0.530 |
Why?
|
| Alcohol Dehydrogenase | 4 | 2007 | 111 | 0.520 |
Why?
|
| Vaccines | 2 | 2022 | 844 | 0.520 |
Why?
|
| Blood Pressure | 3 | 2022 | 8481 | 0.520 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 7 | 2015 | 214 | 0.520 |
Why?
|
| Hypercholesterolemia | 2 | 2022 | 1141 | 0.520 |
Why?
|
| Disease Transmission, Infectious | 2 | 2020 | 560 | 0.510 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 2382 | 0.500 |
Why?
|
| Histiocytosis | 1 | 2015 | 39 | 0.500 |
Why?
|
| Anthropometry | 9 | 2016 | 1349 | 0.500 |
Why?
|
| Cause of Death | 8 | 2024 | 3683 | 0.500 |
Why?
|
| Health Personnel | 6 | 2020 | 3335 | 0.500 |
Why?
|
| Estrogen Replacement Therapy | 16 | 2022 | 1208 | 0.490 |
Why?
|
| Preventive Medicine | 1 | 2017 | 246 | 0.490 |
Why?
|
| Cost of Illness | 4 | 2024 | 1937 | 0.490 |
Why?
|
| Urinary Bladder Neoplasms | 11 | 2023 | 2223 | 0.490 |
Why?
|
| BRCA1 Protein | 8 | 2021 | 1158 | 0.490 |
Why?
|
| Therapeutic Human Experimentation | 1 | 2015 | 43 | 0.490 |
Why?
|
| Nutritional Physiological Phenomena | 6 | 2006 | 363 | 0.490 |
Why?
|
| Ascorbic Acid | 13 | 2010 | 655 | 0.480 |
Why?
|
| ABO Blood-Group System | 7 | 2015 | 380 | 0.480 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 5 | 2007 | 99 | 0.480 |
Why?
|
| Colonic Neoplasms | 12 | 2010 | 2539 | 0.480 |
Why?
|
| Nails | 8 | 2007 | 296 | 0.470 |
Why?
|
| Glutathione Peroxidase | 2 | 2006 | 258 | 0.460 |
Why?
|
| Confidence Intervals | 29 | 2012 | 2927 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2016 | 638 | 0.460 |
Why?
|
| Receptor, Melanocortin, Type 1 | 4 | 2011 | 74 | 0.460 |
Why?
|
| Epoxide Hydrolases | 2 | 2005 | 122 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2011 | 361 | 0.450 |
Why?
|
| Pancreatic Neoplasms | 17 | 2016 | 5368 | 0.450 |
Why?
|
| DNA Repair Enzymes | 6 | 2012 | 346 | 0.450 |
Why?
|
| Internationality | 2 | 2022 | 1001 | 0.450 |
Why?
|
| Age Factors | 52 | 2019 | 18399 | 0.440 |
Why?
|
| Posture | 1 | 2018 | 957 | 0.440 |
Why?
|
| Waist-Hip Ratio | 11 | 2019 | 518 | 0.440 |
Why?
|
| Ethics, Research | 1 | 2015 | 176 | 0.440 |
Why?
|
| Spirurida Infections | 1 | 2013 | 3 | 0.440 |
Why?
|
| Ethics Committees, Research | 1 | 2015 | 196 | 0.440 |
Why?
|
| Proportional Hazards Models | 42 | 2021 | 12463 | 0.440 |
Why?
|
| Trace Elements | 3 | 2005 | 195 | 0.440 |
Why?
|
| Health Surveys | 15 | 2018 | 4061 | 0.430 |
Why?
|
| Acquired Immunodeficiency Syndrome | 7 | 2005 | 2199 | 0.430 |
Why?
|
| Codon | 3 | 2006 | 601 | 0.430 |
Why?
|
| Health Services | 2 | 2018 | 752 | 0.430 |
Why?
|
| C-Reactive Protein | 3 | 2024 | 3826 | 0.430 |
Why?
|
| DNA Methylation | 11 | 2019 | 4399 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2011 | 287 | 0.420 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2024 | 36426 | 0.420 |
Why?
|
| Chronic Disease | 10 | 2017 | 9319 | 0.420 |
Why?
|
| Parkinson Disease | 3 | 2024 | 2877 | 0.420 |
Why?
|
| Knowledge | 1 | 2014 | 177 | 0.410 |
Why?
|
| Cholesterol, HDL | 7 | 2020 | 1814 | 0.400 |
Why?
|
| Poliomyelitis | 1 | 2013 | 92 | 0.400 |
Why?
|
| Glucuronosyltransferase | 5 | 2012 | 132 | 0.400 |
Why?
|
| Genetic Association Studies | 19 | 2024 | 2735 | 0.400 |
Why?
|
| Lung Neoplasms | 18 | 2019 | 13381 | 0.400 |
Why?
|
| Dairy Products | 4 | 2006 | 490 | 0.400 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 3 | 2001 | 28 | 0.390 |
Why?
|
| Body Weight | 14 | 2013 | 4618 | 0.390 |
Why?
|
| Calcium | 3 | 2024 | 5722 | 0.390 |
Why?
|
| Body Constitution | 7 | 2004 | 273 | 0.390 |
Why?
|
| Toll-Like Receptor 6 | 2 | 2010 | 29 | 0.390 |
Why?
|
| Sexually Transmitted Diseases | 7 | 2000 | 662 | 0.380 |
Why?
|
| Joint Instability | 2 | 2009 | 801 | 0.380 |
Why?
|
| Uncertainty | 1 | 2016 | 754 | 0.380 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 2024 | 0.370 |
Why?
|
| Aldehyde Oxidoreductases | 2 | 2001 | 88 | 0.370 |
Why?
|
| Germ Cells | 3 | 2021 | 634 | 0.370 |
Why?
|
| TCF Transcription Factors | 2 | 2008 | 138 | 0.360 |
Why?
|
| Models, Genetic | 16 | 2016 | 3442 | 0.360 |
Why?
|
| Sequence Analysis, DNA | 16 | 2021 | 4740 | 0.360 |
Why?
|
| Menisci, Tibial | 4 | 2018 | 267 | 0.360 |
Why?
|
| Dietary Fiber | 10 | 2013 | 759 | 0.360 |
Why?
|
| Women | 3 | 2001 | 223 | 0.360 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2004 | 858 | 0.360 |
Why?
|
| Government Regulation | 1 | 2015 | 524 | 0.360 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2019 | 1390 | 0.360 |
Why?
|
| Estrone | 6 | 2021 | 234 | 0.360 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 3086 | 0.360 |
Why?
|
| Puberty | 3 | 2024 | 501 | 0.350 |
Why?
|
| Health Services Research | 1 | 2018 | 1812 | 0.350 |
Why?
|
| Climate Change | 1 | 2017 | 501 | 0.350 |
Why?
|
| Transcription Factors | 10 | 2017 | 12130 | 0.350 |
Why?
|
| Sunlight | 4 | 2008 | 337 | 0.350 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 3206 | 0.350 |
Why?
|
| Estradiol | 10 | 2012 | 1937 | 0.350 |
Why?
|
| Breast | 8 | 2022 | 1967 | 0.350 |
Why?
|
| Alcoholic Beverages | 3 | 2014 | 264 | 0.350 |
Why?
|
| Knee Injuries | 1 | 2015 | 488 | 0.340 |
Why?
|
| CD4 Lymphocyte Count | 10 | 2009 | 2571 | 0.340 |
Why?
|
| Epidemiologic Methods | 7 | 2007 | 1336 | 0.340 |
Why?
|
| Telomerase | 6 | 2018 | 745 | 0.340 |
Why?
|
| Neoplasms, Hormone-Dependent | 4 | 2015 | 410 | 0.340 |
Why?
|
| Dimethylnitrosamine | 1 | 2009 | 17 | 0.340 |
Why?
|
| Weight-Bearing | 2 | 2009 | 532 | 0.340 |
Why?
|
| Penetrance | 3 | 2015 | 383 | 0.330 |
Why?
|
| Feeding Behavior | 17 | 2014 | 3188 | 0.330 |
Why?
|
| Insecticides | 3 | 2001 | 191 | 0.330 |
Why?
|
| Nitrosamines | 1 | 2009 | 87 | 0.330 |
Why?
|
| Reproducibility of Results | 40 | 2024 | 20100 | 0.330 |
Why?
|
| Regression Analysis | 26 | 2016 | 6345 | 0.330 |
Why?
|
| Meta-Analysis as Topic | 19 | 2017 | 1380 | 0.330 |
Why?
|
| Dementia | 1 | 2024 | 2689 | 0.320 |
Why?
|
| Adiposity | 8 | 2017 | 1879 | 0.320 |
Why?
|
| Birth Weight | 6 | 2009 | 2103 | 0.320 |
Why?
|
| Leiomyoma | 3 | 1998 | 636 | 0.320 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2018 | 2917 | 0.320 |
Why?
|
| Congresses as Topic | 1 | 2014 | 803 | 0.320 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2010 | 190 | 0.320 |
Why?
|
| Nitrites | 1 | 2009 | 159 | 0.320 |
Why?
|
| Anemia | 7 | 2010 | 1509 | 0.320 |
Why?
|
| Lumbar Vertebrae | 3 | 2007 | 1879 | 0.320 |
Why?
|
| Myocardial Infarction | 8 | 2022 | 11461 | 0.320 |
Why?
|
| Prognosis | 33 | 2024 | 29629 | 0.320 |
Why?
|
| Statistics as Topic | 5 | 2010 | 2358 | 0.320 |
Why?
|
| Prevalence | 27 | 2024 | 15733 | 0.320 |
Why?
|
| Pregnancy | 60 | 2010 | 29890 | 0.320 |
Why?
|
| Diet Surveys | 10 | 2009 | 1162 | 0.310 |
Why?
|
| Kallikreins | 4 | 2011 | 220 | 0.310 |
Why?
|
| Australia | 8 | 2024 | 1250 | 0.310 |
Why?
|
| Pandemics | 5 | 2020 | 8656 | 0.310 |
Why?
|
| Coronary Disease | 12 | 2007 | 5914 | 0.310 |
Why?
|
| BRCA2 Protein | 4 | 2021 | 805 | 0.310 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 4 | 2013 | 92 | 0.310 |
Why?
|
| Weight Gain | 13 | 2023 | 2348 | 0.310 |
Why?
|
| Genes, Neoplasm | 2 | 2011 | 370 | 0.310 |
Why?
|
| Biostatistics | 1 | 2010 | 164 | 0.310 |
Why?
|
| beta Carotene | 6 | 2007 | 523 | 0.310 |
Why?
|
| Cartilage Diseases | 2 | 2023 | 157 | 0.310 |
Why?
|
| Models, Statistical | 10 | 2016 | 5079 | 0.310 |
Why?
|
| HIV Seropositivity | 9 | 2006 | 960 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 2 | 4 | 2016 | 313 | 0.300 |
Why?
|
| Fucosyltransferases | 1 | 2008 | 117 | 0.300 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2008 | 52 | 0.300 |
Why?
|
| Cyclooxygenase 2 | 2 | 2009 | 597 | 0.300 |
Why?
|
| Toll-Like Receptor 10 | 1 | 2007 | 12 | 0.300 |
Why?
|
| Polymerase Chain Reaction | 17 | 2016 | 6075 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2016 | 430 | 0.300 |
Why?
|
| Nitrates | 1 | 2009 | 263 | 0.300 |
Why?
|
| Antiporters | 2 | 2009 | 277 | 0.300 |
Why?
|
| Age of Onset | 6 | 2021 | 3306 | 0.290 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2007 | 48 | 0.290 |
Why?
|
| Adipose Tissue | 9 | 2016 | 3313 | 0.290 |
Why?
|
| Sulfonamides | 2 | 2015 | 1979 | 0.290 |
Why?
|
| Genes | 3 | 2013 | 1823 | 0.290 |
Why?
|
| Macular Degeneration | 3 | 2015 | 1007 | 0.290 |
Why?
|
| One-Carbon Group Transferases | 1 | 2007 | 6 | 0.290 |
Why?
|
| Sexual Behavior | 10 | 2006 | 2180 | 0.290 |
Why?
|
| Family Planning Services | 5 | 2000 | 268 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 19 | 4 | 2014 | 350 | 0.290 |
Why?
|
| Ethanol | 5 | 2005 | 1324 | 0.290 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 4 | 2010 | 127 | 0.290 |
Why?
|
| Genes, BRCA2 | 3 | 2015 | 601 | 0.290 |
Why?
|
| Inheritance Patterns | 4 | 2019 | 341 | 0.290 |
Why?
|
| DNA, Neoplasm | 5 | 2009 | 1745 | 0.290 |
Why?
|
| Cyclin D1 | 2 | 2006 | 451 | 0.280 |
Why?
|
| Indoles | 1 | 2015 | 1833 | 0.280 |
Why?
|
| Mutation | 20 | 2021 | 30053 | 0.280 |
Why?
|
| Breast Feeding | 6 | 2016 | 1360 | 0.280 |
Why?
|
| Disease Progression | 18 | 2024 | 13510 | 0.280 |
Why?
|
| Cardiovascular Diseases | 16 | 2022 | 15502 | 0.280 |
Why?
|
| Membrane Proteins | 11 | 2023 | 7859 | 0.280 |
Why?
|
| Gene Expression | 5 | 2018 | 7581 | 0.280 |
Why?
|
| Mosaicism | 3 | 2016 | 475 | 0.280 |
Why?
|
| Gout | 4 | 2019 | 621 | 0.280 |
Why?
|
| Sex Hormone-Binding Globulin | 5 | 2012 | 550 | 0.270 |
Why?
|
| Evidence-Based Medicine | 6 | 2019 | 3688 | 0.270 |
Why?
|
| Receptors, Androgen | 5 | 2010 | 1079 | 0.270 |
Why?
|
| Antioxidants | 8 | 2008 | 1668 | 0.270 |
Why?
|
| Phenotype | 27 | 2020 | 16592 | 0.270 |
Why?
|
| Genes, BRCA1 | 3 | 2015 | 764 | 0.270 |
Why?
|
| Dietary Proteins | 6 | 2014 | 952 | 0.270 |
Why?
|
| Aged, 80 and over | 51 | 2024 | 58984 | 0.270 |
Why?
|
| Calcium, Dietary | 3 | 2006 | 529 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 13 | 2016 | 5790 | 0.270 |
Why?
|
| Microsatellite Repeats | 4 | 2010 | 784 | 0.270 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2010 | 579 | 0.270 |
Why?
|
| Energy Intake | 15 | 2018 | 2134 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 10 | 4 | 2011 | 277 | 0.260 |
Why?
|
| Prostatic Secretory Proteins | 3 | 2010 | 24 | 0.260 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2007 | 302 | 0.260 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2015 | 2057 | 0.260 |
Why?
|
| Arginine | 2 | 2006 | 934 | 0.260 |
Why?
|
| Spinal Stenosis | 1 | 2009 | 261 | 0.260 |
Why?
|
| Cytochrome P-450 CYP1A1 | 4 | 2003 | 90 | 0.260 |
Why?
|
| Biosynthetic Pathways | 1 | 2006 | 136 | 0.260 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2016 | 2805 | 0.260 |
Why?
|
| Adiponectin | 6 | 2014 | 1113 | 0.250 |
Why?
|
| Spondylolisthesis | 1 | 2007 | 175 | 0.250 |
Why?
|
| Empirical Research | 1 | 2006 | 120 | 0.250 |
Why?
|
| Double-Blind Method | 19 | 2019 | 12341 | 0.250 |
Why?
|
| Hormones | 4 | 2010 | 869 | 0.250 |
Why?
|
| Body Size | 4 | 2016 | 463 | 0.250 |
Why?
|
| Exercise Therapy | 4 | 2024 | 929 | 0.250 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2009 | 423 | 0.250 |
Why?
|
| Tocopherols | 1 | 2005 | 44 | 0.250 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2007 | 295 | 0.250 |
Why?
|
| Genes, ras | 2 | 2008 | 654 | 0.250 |
Why?
|
| Zygapophyseal Joint | 1 | 2007 | 128 | 0.240 |
Why?
|
| Uterine Neoplasms | 3 | 1998 | 1420 | 0.240 |
Why?
|
| Environmental Exposure | 7 | 2014 | 4485 | 0.240 |
Why?
|
| Sample Size | 5 | 2022 | 841 | 0.240 |
Why?
|
| Carcinoma | 7 | 2011 | 2330 | 0.240 |
Why?
|
| Environment | 4 | 2011 | 1123 | 0.240 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 746 | 0.240 |
Why?
|
| Immunologic Factors | 2 | 2019 | 1590 | 0.240 |
Why?
|
| Genes, erbB-2 | 1 | 2005 | 162 | 0.240 |
Why?
|
| Malaria | 4 | 2013 | 1227 | 0.240 |
Why?
|
| Age Distribution | 12 | 2024 | 2879 | 0.240 |
Why?
|
| Diethylstilbestrol | 1 | 2004 | 87 | 0.240 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2004 | 52 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 18 | 5 | 2011 | 247 | 0.240 |
Why?
|
| Cytochrome P-450 CYP1A2 | 3 | 2014 | 69 | 0.240 |
Why?
|
| Glycine Hydroxymethyltransferase | 3 | 2010 | 32 | 0.230 |
Why?
|
| Policy Making | 2 | 2018 | 542 | 0.230 |
Why?
|
| Mammography | 7 | 2012 | 2430 | 0.230 |
Why?
|
| Principal Component Analysis | 7 | 2016 | 945 | 0.230 |
Why?
|
| Genetics, Population | 3 | 2014 | 937 | 0.230 |
Why?
|
| Cognition | 2 | 2019 | 6992 | 0.230 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2004 | 2518 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2017 | 8554 | 0.230 |
Why?
|
| Primary Health Care | 2 | 2024 | 4687 | 0.230 |
Why?
|
| Patellofemoral Pain Syndrome | 1 | 2023 | 17 | 0.230 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 2005 | 218 | 0.230 |
Why?
|
| Angiotensinogen | 1 | 2024 | 161 | 0.230 |
Why?
|
| Carcinogens | 4 | 2012 | 452 | 0.220 |
Why?
|
| Longitudinal Studies | 14 | 2024 | 14608 | 0.220 |
Why?
|
| Pregnancy, Multiple | 1 | 2004 | 215 | 0.220 |
Why?
|
| Glioma | 4 | 2013 | 3455 | 0.220 |
Why?
|
| Eating | 4 | 2013 | 1539 | 0.220 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2007 | 389 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 2015 | 535 | 0.220 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 629 | 0.220 |
Why?
|
| Estrogen Receptor alpha | 6 | 2017 | 583 | 0.220 |
Why?
|
| Disease | 1 | 2009 | 672 | 0.220 |
Why?
|
| Bisexuality | 3 | 2020 | 294 | 0.220 |
Why?
|
| Minerals | 1 | 2005 | 283 | 0.220 |
Why?
|
| Parity | 12 | 2010 | 927 | 0.220 |
Why?
|
| HIV Seroprevalence | 3 | 2006 | 89 | 0.220 |
Why?
|
| Homozygote | 7 | 2008 | 1776 | 0.220 |
Why?
|
| Cross-Sectional Studies | 29 | 2024 | 26129 | 0.220 |
Why?
|
| Body Fat Distribution | 3 | 2017 | 245 | 0.210 |
Why?
|
| Tobacco Use Disorder | 3 | 2019 | 703 | 0.210 |
Why?
|
| Caffeine | 3 | 2015 | 700 | 0.210 |
Why?
|
| Nevus, Pigmented | 2 | 2018 | 222 | 0.210 |
Why?
|
| Minisatellite Repeats | 1 | 2003 | 163 | 0.210 |
Why?
|
| Methionine | 7 | 2007 | 572 | 0.210 |
Why?
|
| Dinucleotide Repeats | 1 | 2002 | 29 | 0.210 |
Why?
|
| Cooking | 6 | 2014 | 315 | 0.210 |
Why?
|
| Aspirin | 9 | 2013 | 3133 | 0.210 |
Why?
|
| Zinc | 3 | 2005 | 690 | 0.210 |
Why?
|
| Tandem Repeat Sequences | 1 | 2003 | 180 | 0.210 |
Why?
|
| Athletic Performance | 1 | 2024 | 111 | 0.210 |
Why?
|
| Depression | 6 | 2018 | 8126 | 0.210 |
Why?
|
| Aging | 8 | 2021 | 8710 | 0.210 |
Why?
|
| Caspases | 1 | 2006 | 879 | 0.210 |
Why?
|
| Condoms | 4 | 2009 | 331 | 0.210 |
Why?
|
| Beauty Culture | 2 | 2013 | 41 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2019 | 310 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2016 | 192 | 0.210 |
Why?
|
| Genetics, Medical | 1 | 2005 | 334 | 0.210 |
Why?
|
| Research Design | 16 | 2019 | 6180 | 0.210 |
Why?
|
| Bone Marrow Diseases | 1 | 2024 | 233 | 0.200 |
Why?
|
| Contraception | 3 | 1997 | 349 | 0.200 |
Why?
|
| Codon, Terminator | 1 | 2002 | 124 | 0.200 |
Why?
|
| Forecasting | 5 | 2024 | 2928 | 0.200 |
Why?
|
| Calcaneus | 2 | 2001 | 142 | 0.200 |
Why?
|
| Adolescent | 50 | 2024 | 88326 | 0.200 |
Why?
|
| Proteins | 8 | 2015 | 6032 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 6 | 2018 | 4415 | 0.200 |
Why?
|
| Genetic Research | 2 | 2006 | 171 | 0.200 |
Why?
|
| Mammary Glands, Human | 2 | 2014 | 203 | 0.200 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 1126 | 0.200 |
Why?
|
| Synovial Membrane | 3 | 2011 | 532 | 0.200 |
Why?
|
| Triglycerides | 4 | 2022 | 2461 | 0.200 |
Why?
|
| Medical History Taking | 6 | 2021 | 774 | 0.200 |
Why?
|
| History, 20th Century | 4 | 2020 | 2767 | 0.190 |
Why?
|
| Interleukin-6 | 4 | 2019 | 3208 | 0.190 |
Why?
|
| Review Literature as Topic | 1 | 2024 | 348 | 0.190 |
Why?
|
| Time Factors | 35 | 2024 | 39969 | 0.190 |
Why?
|
| Women's Health | 11 | 2013 | 2065 | 0.190 |
Why?
|
| Canada | 4 | 2018 | 2122 | 0.190 |
Why?
|
| Pregnancy Outcome | 8 | 2009 | 2922 | 0.190 |
Why?
|
| Pregnanediol | 1 | 2021 | 18 | 0.190 |
Why?
|
| Residence Characteristics | 4 | 2017 | 2095 | 0.190 |
Why?
|
| Vitamin B Complex | 3 | 2015 | 299 | 0.190 |
Why?
|
| Genetic Pleiotropy | 2 | 2021 | 181 | 0.190 |
Why?
|
| DNA Helicases | 2 | 2012 | 851 | 0.190 |
Why?
|
| ROC Curve | 9 | 2024 | 3578 | 0.180 |
Why?
|
| Epigenesis, Genetic | 6 | 2019 | 3801 | 0.180 |
Why?
|
| Anemia, Iron-Deficiency | 4 | 2010 | 369 | 0.180 |
Why?
|
| Diabetic Angiopathies | 4 | 2006 | 803 | 0.180 |
Why?
|
| Neoplasm Proteins | 5 | 2019 | 3617 | 0.180 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2021 | 114 | 0.180 |
Why?
|
| National Cancer Institute (U.S.) | 5 | 2013 | 297 | 0.180 |
Why?
|
| Sensitivity and Specificity | 18 | 2024 | 14665 | 0.180 |
Why?
|
| Ultraviolet Rays | 4 | 2014 | 1080 | 0.180 |
Why?
|
| Adenocarcinoma | 6 | 2015 | 6345 | 0.180 |
Why?
|
| Range of Motion, Articular | 4 | 2022 | 1588 | 0.180 |
Why?
|
| Disease Susceptibility | 11 | 2018 | 1787 | 0.180 |
Why?
|
| Bedding and Linens | 1 | 2000 | 41 | 0.180 |
Why?
|
| Dietary Carbohydrates | 4 | 2014 | 891 | 0.170 |
Why?
|
| Membrane Glycoproteins | 3 | 2011 | 3701 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2017 | 1651 | 0.170 |
Why?
|
| Carcinoma in Situ | 3 | 2015 | 791 | 0.170 |
Why?
|
| Insulin | 4 | 2019 | 6597 | 0.170 |
Why?
|
| Oxidative Stress | 6 | 2009 | 3113 | 0.170 |
Why?
|
| Iron | 4 | 2007 | 1793 | 0.170 |
Why?
|
| Cooperative Behavior | 6 | 2013 | 1505 | 0.170 |
Why?
|
| Obesity, Abdominal | 2 | 2022 | 374 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2014 | 418 | 0.170 |
Why?
|
| Epistasis, Genetic | 5 | 2017 | 352 | 0.170 |
Why?
|
| North America | 8 | 2010 | 1276 | 0.170 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2002 | 412 | 0.170 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 4 | 2023 | 152 | 0.170 |
Why?
|
| Long Interspersed Nucleotide Elements | 3 | 2010 | 330 | 0.170 |
Why?
|
| Mental Health | 3 | 2017 | 3250 | 0.170 |
Why?
|
| Infant, Newborn | 23 | 2017 | 26202 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 3 | 2010 | 208 | 0.170 |
Why?
|
| Reproduction | 4 | 2015 | 645 | 0.170 |
Why?
|
| Antigens, Viral | 2 | 2020 | 988 | 0.170 |
Why?
|
| Receptor, erbB-2 | 4 | 2022 | 2557 | 0.170 |
Why?
|
| Electricity | 1 | 2000 | 181 | 0.170 |
Why?
|
| Local Government | 2 | 2020 | 81 | 0.170 |
Why?
|
| Environmental Pollution | 2 | 2017 | 124 | 0.160 |
Why?
|
| Infertility, Female | 6 | 2006 | 760 | 0.160 |
Why?
|
| Twins | 1 | 2001 | 339 | 0.160 |
Why?
|
| False Positive Reactions | 3 | 2012 | 957 | 0.160 |
Why?
|
| Coffee | 3 | 2015 | 593 | 0.160 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 206 | 0.160 |
Why?
|
| Signal Transduction | 13 | 2020 | 23447 | 0.160 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2005 | 1802 | 0.160 |
Why?
|
| Ovary | 2 | 2021 | 959 | 0.160 |
Why?
|
| Laparoscopy | 4 | 2005 | 2036 | 0.160 |
Why?
|
| Homeodomain Proteins | 3 | 2020 | 2418 | 0.160 |
Why?
|
| Pain | 4 | 2024 | 5073 | 0.160 |
Why?
|
| Prostate-Specific Antigen | 5 | 2012 | 2469 | 0.160 |
Why?
|
| Medical Oncology | 3 | 2016 | 2321 | 0.160 |
Why?
|
| Acne Vulgaris | 2 | 2015 | 358 | 0.160 |
Why?
|
| Hyperlipidemias | 2 | 2022 | 771 | 0.160 |
Why?
|
| Neoplasm Staging | 12 | 2021 | 11120 | 0.160 |
Why?
|
| Puberty, Delayed | 3 | 2024 | 121 | 0.160 |
Why?
|
| Reference Values | 10 | 2009 | 4920 | 0.160 |
Why?
|
| Primary Ovarian Insufficiency | 3 | 2021 | 107 | 0.160 |
Why?
|
| DNA Damage | 3 | 2015 | 2449 | 0.150 |
Why?
|
| DNA Modification Methylases | 3 | 2009 | 210 | 0.150 |
Why?
|
| Fishes | 4 | 2003 | 603 | 0.150 |
Why?
|
| Chromosomes, Human | 2 | 2011 | 441 | 0.150 |
Why?
|
| Eggs | 3 | 2006 | 182 | 0.150 |
Why?
|
| Workload | 1 | 2004 | 844 | 0.150 |
Why?
|
| Income | 2 | 2022 | 1877 | 0.150 |
Why?
|
| Work Schedule Tolerance | 3 | 2012 | 551 | 0.150 |
Why?
|
| Fatty Acids | 4 | 1999 | 1808 | 0.150 |
Why?
|
| Membrane Transport Proteins | 4 | 2011 | 1035 | 0.150 |
Why?
|
| Estrogen Receptor beta | 3 | 2008 | 168 | 0.150 |
Why?
|
| Linear Models | 11 | 2013 | 5872 | 0.150 |
Why?
|
| Public Health Practice | 1 | 2020 | 219 | 0.150 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2000 | 412 | 0.150 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 11904 | 0.150 |
Why?
|
| Nutrition Therapy | 1 | 2019 | 102 | 0.150 |
Why?
|
| Public Health Administration | 1 | 2020 | 242 | 0.150 |
Why?
|
| Mental Recall | 5 | 2006 | 1221 | 0.150 |
Why?
|
| Heterozygote | 9 | 2017 | 2787 | 0.150 |
Why?
|
| Football | 1 | 2024 | 503 | 0.150 |
Why?
|
| Diet Records | 4 | 1998 | 427 | 0.150 |
Why?
|
| Cytosine | 1 | 2019 | 211 | 0.150 |
Why?
|
| Amino Acid Substitution | 5 | 2007 | 1739 | 0.150 |
Why?
|
| Sex Characteristics | 7 | 2015 | 2639 | 0.150 |
Why?
|
| History, 21st Century | 3 | 2020 | 1567 | 0.150 |
Why?
|
| Receptor, Melanocortin, Type 4 | 2 | 2008 | 129 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2016 | 127 | 0.150 |
Why?
|
| Coronary Artery Disease | 4 | 2024 | 6403 | 0.150 |
Why?
|
| Vitamin D Deficiency | 5 | 2011 | 1388 | 0.140 |
Why?
|
| Radiography | 5 | 2024 | 6965 | 0.140 |
Why?
|
| Isoenzymes | 2 | 2001 | 1687 | 0.140 |
Why?
|
| Brain Neoplasms | 4 | 2013 | 9032 | 0.140 |
Why?
|
| Catechol O-Methyltransferase | 3 | 2004 | 251 | 0.140 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 2 | 2007 | 13 | 0.140 |
Why?
|
| Retinoids | 1 | 1997 | 99 | 0.140 |
Why?
|
| Human Genome Project | 3 | 2006 | 200 | 0.140 |
Why?
|
| Exudates and Transudates | 1 | 2017 | 174 | 0.140 |
Why?
|
| Hormone Replacement Therapy | 4 | 2022 | 751 | 0.140 |
Why?
|
| Activin Receptors, Type II | 1 | 2017 | 123 | 0.140 |
Why?
|
| Likelihood Functions | 7 | 2010 | 992 | 0.140 |
Why?
|
| Ribonucleoproteins | 2 | 2017 | 372 | 0.140 |
Why?
|
| Prostatic Diseases | 1 | 1997 | 57 | 0.140 |
Why?
|
| Environmental Monitoring | 2 | 2009 | 1460 | 0.140 |
Why?
|
| Anticarcinogenic Agents | 2 | 2013 | 250 | 0.140 |
Why?
|
| Menopause, Premature | 2 | 2021 | 124 | 0.140 |
Why?
|
| Internet | 5 | 2017 | 3093 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2023 | 1076 | 0.140 |
Why?
|
| Lymphoma, Non-Hodgkin | 5 | 2015 | 1374 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2001 | 4016 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2013 | 2273 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5314 | 0.140 |
Why?
|
| Complement Factor H | 2 | 2007 | 110 | 0.140 |
Why?
|
| Menstrual Cycle | 5 | 2024 | 539 | 0.140 |
Why?
|
| Infant Mortality | 5 | 2009 | 759 | 0.140 |
Why?
|
| Genetic Linkage | 4 | 2013 | 2341 | 0.140 |
Why?
|
| Progesterone | 1 | 2021 | 742 | 0.140 |
Why?
|
| Health Promotion | 4 | 2015 | 2214 | 0.140 |
Why?
|
| Circumcision, Male | 2 | 1998 | 148 | 0.130 |
Why?
|
| Data Collection | 4 | 2006 | 3322 | 0.130 |
Why?
|
| Microfilament Proteins | 5 | 2018 | 1134 | 0.130 |
Why?
|
| Lactation | 3 | 2004 | 397 | 0.130 |
Why?
|
| Gonorrhea | 3 | 1998 | 346 | 0.130 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.130 |
Why?
|
| Puberty, Precocious | 2 | 2024 | 164 | 0.130 |
Why?
|
| Amines | 2 | 2013 | 281 | 0.130 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 2 | 2007 | 106 | 0.130 |
Why?
|
| Herpesvirus 4, Human | 1 | 2001 | 1078 | 0.130 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2000 | 592 | 0.130 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 2 | 2006 | 56 | 0.130 |
Why?
|
| Mass Screening | 4 | 2020 | 5429 | 0.130 |
Why?
|
| Urination Disorders | 1 | 1997 | 238 | 0.130 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 1999 | 384 | 0.130 |
Why?
|
| Shoes | 1 | 2016 | 92 | 0.130 |
Why?
|
| Capacity Building | 1 | 2018 | 258 | 0.130 |
Why?
|
| DNA | 7 | 2013 | 7213 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Blood Specimen Collection | 1 | 1997 | 238 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1062 | 0.130 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2017 | 266 | 0.130 |
Why?
|
| Androgens | 3 | 2005 | 1286 | 0.130 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 3 | 2013 | 174 | 0.130 |
Why?
|
| Stomatognathic Diseases | 1 | 2015 | 22 | 0.130 |
Why?
|
| Toes | 5 | 1996 | 209 | 0.130 |
Why?
|
| E-Selectin | 2 | 2010 | 576 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 368 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2001 | 612 | 0.120 |
Why?
|
| Lymphedema | 1 | 2022 | 525 | 0.120 |
Why?
|
| Severity of Illness Index | 8 | 2024 | 15843 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 4 | 2021 | 522 | 0.120 |
Why?
|
| Lactose | 2 | 2006 | 95 | 0.120 |
Why?
|
| Health Education | 2 | 1993 | 1052 | 0.120 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2016 | 543 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2006 | 2827 | 0.120 |
Why?
|
| Databases, Genetic | 7 | 2021 | 1742 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2014 | 3779 | 0.120 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2015 | 82 | 0.120 |
Why?
|
| Informed Consent | 2 | 2001 | 1008 | 0.120 |
Why?
|
| Quality Control | 6 | 2013 | 832 | 0.120 |
Why?
|
| Environmental Health | 1 | 2017 | 290 | 0.120 |
Why?
|
| Dyssomnias | 1 | 2014 | 28 | 0.120 |
Why?
|
| Peer Group | 1 | 2020 | 692 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2013 | 789 | 0.120 |
Why?
|
| Coffea | 1 | 2014 | 22 | 0.120 |
Why?
|
| Chlamydia Infections | 2 | 2003 | 365 | 0.120 |
Why?
|
| Proline | 3 | 2006 | 457 | 0.120 |
Why?
|
| Beverages | 2 | 2012 | 821 | 0.120 |
Why?
|
| Foundations | 1 | 2015 | 95 | 0.120 |
Why?
|
| DNA, Mitochondrial | 2 | 2018 | 865 | 0.120 |
Why?
|
| Multiple Sclerosis | 3 | 2011 | 3222 | 0.120 |
Why?
|
| Epidemiologic Research Design | 2 | 2003 | 368 | 0.120 |
Why?
|
| Probability | 5 | 2009 | 2477 | 0.120 |
Why?
|
| Foreign Professional Personnel | 1 | 2014 | 9 | 0.120 |
Why?
|
| Psychometrics | 1 | 2024 | 3065 | 0.120 |
Why?
|
| CpG Islands | 2 | 2010 | 1230 | 0.120 |
Why?
|
| Introns | 5 | 2017 | 981 | 0.120 |
Why?
|
| Self Report | 2 | 2024 | 3725 | 0.120 |
Why?
|
| Phosphofructokinase-1, Muscle Type | 1 | 2014 | 4 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 3 | 2024 | 999 | 0.120 |
Why?
|
| Education, Graduate | 1 | 2015 | 75 | 0.120 |
Why?
|
| Syphilis | 2 | 1994 | 243 | 0.120 |
Why?
|
| Trichomonas Vaginitis | 1 | 1994 | 33 | 0.120 |
Why?
|
| Inflammation | 4 | 2015 | 10774 | 0.120 |
Why?
|
| Financial Support | 1 | 2015 | 117 | 0.120 |
Why?
|
| Developed Countries | 2 | 2013 | 449 | 0.120 |
Why?
|
| Radiation, Ionizing | 2 | 2010 | 251 | 0.120 |
Why?
|
| Dissent and Disputes | 1 | 2015 | 146 | 0.120 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 321 | 0.120 |
Why?
|
| Cholesterol | 5 | 2016 | 2905 | 0.110 |
Why?
|
| Cyclin E | 1 | 2014 | 156 | 0.110 |
Why?
|
| Receptors, Nicotinic | 2 | 2015 | 495 | 0.110 |
Why?
|
| DNA Primers | 4 | 2007 | 2820 | 0.110 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 227 | 0.110 |
Why?
|
| Caspase 8 | 1 | 2014 | 190 | 0.110 |
Why?
|
| PPAR gamma | 3 | 2007 | 484 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 495 | 0.110 |
Why?
|
| DNA Ligases | 2 | 2004 | 82 | 0.110 |
Why?
|
| Somatotypes | 1 | 1994 | 41 | 0.110 |
Why?
|
| Sexual Partners | 6 | 2009 | 796 | 0.110 |
Why?
|
| Apolipoprotein C-III | 2 | 2024 | 211 | 0.110 |
Why?
|
| Mental Disorders | 2 | 2019 | 6845 | 0.110 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 836 | 0.110 |
Why?
|
| Prenatal Care | 5 | 2009 | 1141 | 0.110 |
Why?
|
| Casein Kinase II | 1 | 2014 | 122 | 0.110 |
Why?
|
| HIV Wasting Syndrome | 2 | 2005 | 99 | 0.110 |
Why?
|
| Socioeconomic Factors | 6 | 2015 | 7828 | 0.110 |
Why?
|
| Athletic Injuries | 1 | 2024 | 1216 | 0.110 |
Why?
|
| Urbanization | 1 | 2014 | 100 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2018 | 1494 | 0.110 |
Why?
|
| Xenobiotics | 1 | 2013 | 70 | 0.110 |
Why?
|
| Glycine | 2 | 2014 | 663 | 0.110 |
Why?
|
| Nutritional Status | 5 | 2010 | 1615 | 0.110 |
Why?
|
| Gallstones | 1 | 2016 | 284 | 0.110 |
Why?
|
| Economics | 1 | 2014 | 141 | 0.110 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2002 | 589 | 0.110 |
Why?
|
| Social Behavior | 1 | 2020 | 1135 | 0.110 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2013 | 549 | 0.110 |
Why?
|
| Overweight | 6 | 2024 | 2417 | 0.110 |
Why?
|
| Lipase | 2 | 2006 | 325 | 0.110 |
Why?
|
| Weight Loss | 4 | 2024 | 2684 | 0.110 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2005 | 2020 | 0.110 |
Why?
|
| Carcinoma, Lobular | 2 | 2013 | 481 | 0.110 |
Why?
|
| Bayes Theorem | 5 | 2023 | 2330 | 0.110 |
Why?
|
| Humidity | 1 | 2014 | 205 | 0.110 |
Why?
|
| Alcoholism | 1 | 2004 | 1973 | 0.110 |
Why?
|
| Research Personnel | 1 | 2018 | 588 | 0.110 |
Why?
|
| Leucine | 2 | 2004 | 548 | 0.110 |
Why?
|
| Gene Expression Profiling | 7 | 2018 | 9420 | 0.110 |
Why?
|
| Hysterectomy | 5 | 1998 | 857 | 0.110 |
Why?
|
| Arsenic | 3 | 2007 | 362 | 0.110 |
Why?
|
| Hypersensitivity | 2 | 2013 | 1171 | 0.110 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2009 | 3165 | 0.110 |
Why?
|
| Ethics, Medical | 4 | 1999 | 783 | 0.110 |
Why?
|
| Cyclin D2 | 1 | 2012 | 98 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2010 | 783 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2001 | 2025 | 0.100 |
Why?
|
| Body Weights and Measures | 1 | 2013 | 208 | 0.100 |
Why?
|
| Proteomics | 1 | 2006 | 3848 | 0.100 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2017 | 487 | 0.100 |
Why?
|
| Demography | 3 | 2009 | 1648 | 0.100 |
Why?
|
| Sunbathing | 2 | 2013 | 65 | 0.100 |
Why?
|
| Sex Factors | 12 | 2012 | 10554 | 0.100 |
Why?
|
| Valine | 2 | 2004 | 408 | 0.100 |
Why?
|
| Health Care Reform | 2 | 2009 | 1247 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 68 | 0.100 |
Why?
|
| Sex Distribution | 6 | 2024 | 2280 | 0.100 |
Why?
|
| Milk | 3 | 2007 | 443 | 0.100 |
Why?
|
| Chromosome Deletion | 1 | 1997 | 1386 | 0.100 |
Why?
|
| Professional Practice | 1 | 2014 | 313 | 0.100 |
Why?
|
| Kenya | 6 | 1995 | 758 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13642 | 0.100 |
Why?
|
| Suntan | 1 | 2012 | 17 | 0.100 |
Why?
|
| Pesticide Residues | 1 | 1993 | 95 | 0.100 |
Why?
|
| Health Priorities | 1 | 2015 | 374 | 0.100 |
Why?
|
| Dystocia | 1 | 1992 | 33 | 0.100 |
Why?
|
| Waist Circumference | 5 | 2017 | 935 | 0.100 |
Why?
|
| Protein Isoforms | 3 | 2012 | 1699 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 6 | 2021 | 3597 | 0.100 |
Why?
|
| Mannose-Binding Lectin | 1 | 2013 | 145 | 0.100 |
Why?
|
| Receptors, LHRH | 2 | 2009 | 158 | 0.100 |
Why?
|
| Pregnancy in Diabetics | 2 | 1993 | 197 | 0.100 |
Why?
|
| Medical Records | 2 | 1997 | 1408 | 0.100 |
Why?
|
| Viral Load | 5 | 2007 | 3332 | 0.100 |
Why?
|
| Cross-Over Studies | 5 | 2022 | 2079 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2010 | 20568 | 0.100 |
Why?
|
| Area Under Curve | 3 | 2011 | 1638 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2010 | 346 | 0.100 |
Why?
|
| Fetal Diseases | 3 | 2002 | 913 | 0.100 |
Why?
|
| Nutrition Surveys | 6 | 2010 | 1733 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2015 | 1136 | 0.100 |
Why?
|
| Cervix Uteri | 2 | 1992 | 570 | 0.100 |
Why?
|
| Mortality | 6 | 2004 | 2902 | 0.100 |
Why?
|
| Antibodies, Viral | 2 | 2001 | 3156 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2012 | 228 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2010 | 322 | 0.100 |
Why?
|
| Animals | 25 | 2024 | 168475 | 0.100 |
Why?
|
| Fats, Unsaturated | 2 | 2003 | 21 | 0.100 |
Why?
|
| Mouth Mucosa | 3 | 2015 | 432 | 0.100 |
Why?
|
| Marital Status | 3 | 2000 | 426 | 0.100 |
Why?
|
| Transcobalamins | 2 | 2010 | 19 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2011 | 2865 | 0.090 |
Why?
|
| Analgesics | 2 | 2009 | 1070 | 0.090 |
Why?
|
| Survival Analysis | 8 | 2021 | 10090 | 0.090 |
Why?
|
| Incidental Findings | 1 | 2016 | 697 | 0.090 |
Why?
|
| Chromosome Aberrations | 2 | 2015 | 1768 | 0.090 |
Why?
|
| Osteosarcoma | 2 | 2015 | 897 | 0.090 |
Why?
|
| Lymphocyte Count | 4 | 2005 | 778 | 0.090 |
Why?
|
| Physical Chromosome Mapping | 1 | 2011 | 183 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 5493 | 0.090 |
Why?
|
| Self Care | 1 | 2016 | 796 | 0.090 |
Why?
|
| Child | 16 | 2024 | 80158 | 0.090 |
Why?
|
| Young Adult | 17 | 2024 | 59260 | 0.090 |
Why?
|
| Chromosomes, Human, Y | 1 | 2012 | 161 | 0.090 |
Why?
|
| Leukocytes | 3 | 2014 | 2026 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2019 | 4352 | 0.090 |
Why?
|
| Hot Temperature | 2 | 2014 | 1440 | 0.090 |
Why?
|
| Chlamydia trachomatis | 1 | 1992 | 239 | 0.090 |
Why?
|
| Developing Countries | 7 | 2017 | 2885 | 0.090 |
Why?
|
| Population Groups | 2 | 2009 | 208 | 0.090 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2010 | 49 | 0.090 |
Why?
|
| Drinking Behavior | 1 | 2011 | 103 | 0.090 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3514 | 0.090 |
Why?
|
| Bone Density | 4 | 2010 | 3551 | 0.090 |
Why?
|
| Amide Synthases | 1 | 2010 | 14 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 4062 | 0.090 |
Why?
|
| Selection Bias | 1 | 2012 | 359 | 0.090 |
Why?
|
| Dietary Sucrose | 1 | 2012 | 243 | 0.090 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2010 | 57 | 0.090 |
Why?
|
| Avitaminosis | 1 | 2010 | 35 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2018 | 1403 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 719 | 0.090 |
Why?
|
| Alanine | 4 | 2009 | 609 | 0.090 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2010 | 61 | 0.090 |
Why?
|
| Labor, Obstetric | 2 | 1999 | 323 | 0.090 |
Why?
|
| Observation | 1 | 2012 | 310 | 0.090 |
Why?
|
| Oxidoreductases | 2 | 2009 | 413 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2015 | 999 | 0.090 |
Why?
|
| India | 3 | 2024 | 2348 | 0.090 |
Why?
|
| Statistics, Nonparametric | 4 | 2007 | 2850 | 0.090 |
Why?
|
| Jews | 1 | 2012 | 356 | 0.090 |
Why?
|
| Tissue Kallikreins | 1 | 2009 | 14 | 0.090 |
Why?
|
| Somatomedins | 1 | 2010 | 179 | 0.090 |
Why?
|
| Educational Status | 6 | 2005 | 2522 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2020 | 790 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 410 | 0.090 |
Why?
|
| Mutation, Missense | 5 | 2008 | 2571 | 0.090 |
Why?
|
| Affect | 1 | 2017 | 1486 | 0.090 |
Why?
|
| Folic Acid Deficiency | 2 | 2003 | 117 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2009 | 17 | 0.080 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 519 | 0.080 |
Why?
|
| Inflammation Mediators | 2 | 2010 | 1886 | 0.080 |
Why?
|
| Diabetes Complications | 2 | 2013 | 1315 | 0.080 |
Why?
|
| Receptors, Somatostatin | 1 | 2010 | 136 | 0.080 |
Why?
|
| Calcifediol | 2 | 2007 | 161 | 0.080 |
Why?
|
| Technology, Radiologic | 1 | 2010 | 160 | 0.080 |
Why?
|
| Tea | 2 | 2008 | 288 | 0.080 |
Why?
|
| Lysophospholipase | 1 | 2009 | 66 | 0.080 |
Why?
|
| Patella | 2 | 2009 | 315 | 0.080 |
Why?
|
| Hemoglobins | 4 | 2010 | 1526 | 0.080 |
Why?
|
| Kidney Neoplasms | 4 | 2015 | 4251 | 0.080 |
Why?
|
| Parenting | 1 | 2015 | 701 | 0.080 |
Why?
|
| Carbon | 1 | 2013 | 666 | 0.080 |
Why?
|
| Transcription Factor AP-2 | 1 | 2009 | 80 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2014 | 728 | 0.080 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2010 | 131 | 0.080 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2016 | 738 | 0.080 |
Why?
|
| Meat Products | 1 | 2009 | 96 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2017 | 12794 | 0.080 |
Why?
|
| Biomedical Research | 2 | 2016 | 3429 | 0.080 |
Why?
|
| Child, Preschool | 10 | 2017 | 42232 | 0.080 |
Why?
|
| Calcitriol | 2 | 2007 | 296 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2005 | 1349 | 0.080 |
Why?
|
| Blood Glucose | 4 | 2019 | 6391 | 0.080 |
Why?
|
| Acetylation | 3 | 2016 | 1055 | 0.080 |
Why?
|
| Genome, Mitochondrial | 1 | 2009 | 66 | 0.080 |
Why?
|
| Acrylamide | 1 | 2009 | 59 | 0.080 |
Why?
|
| Prostatectomy | 1 | 1997 | 1824 | 0.080 |
Why?
|
| Morbidity | 4 | 2009 | 1752 | 0.080 |
Why?
|
| Hip Joint | 2 | 2009 | 1014 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2024 | 3763 | 0.080 |
Why?
|
| Safe Sex | 1 | 2009 | 144 | 0.080 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2008 | 22 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 727 | 0.080 |
Why?
|
| Epidemiology | 2 | 2008 | 279 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2018 | 5247 | 0.080 |
Why?
|
| beta Catenin | 1 | 2013 | 1040 | 0.080 |
Why?
|
| Allied Health Personnel | 1 | 2010 | 155 | 0.080 |
Why?
|
| Precancerous Conditions | 2 | 2010 | 980 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2011 | 1085 | 0.080 |
Why?
|
| Selenoproteins | 1 | 2010 | 215 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1616 | 0.080 |
Why?
|
| Receptors, Leptin | 1 | 2010 | 350 | 0.080 |
Why?
|
| Health Planning Guidelines | 1 | 2009 | 151 | 0.080 |
Why?
|
| Recombination, Genetic | 4 | 2001 | 1519 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2011 | 10212 | 0.080 |
Why?
|
| Vitamin B 6 | 2 | 2015 | 234 | 0.080 |
Why?
|
| Uracil | 1 | 2009 | 207 | 0.080 |
Why?
|
| Interleukin-18 | 1 | 2010 | 250 | 0.080 |
Why?
|
| Air Pollution | 1 | 2022 | 2359 | 0.080 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2005 | 513 | 0.080 |
Why?
|
| Menstruation | 3 | 2005 | 307 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2008 | 1809 | 0.070 |
Why?
|
| Comorbidity | 6 | 2017 | 10508 | 0.070 |
Why?
|
| Multigene Family | 2 | 2010 | 1076 | 0.070 |
Why?
|
| Fats | 1 | 2008 | 99 | 0.070 |
Why?
|
| Computational Biology | 5 | 2020 | 3517 | 0.070 |
Why?
|
| Base Sequence | 8 | 2012 | 12441 | 0.070 |
Why?
|
| Orthotic Devices | 1 | 2009 | 129 | 0.070 |
Why?
|
| Blood Cells | 1 | 2010 | 305 | 0.070 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2009 | 274 | 0.070 |
Why?
|
| Interviews as Topic | 2 | 2006 | 2696 | 0.070 |
Why?
|
| Contraception Behavior | 3 | 1995 | 182 | 0.070 |
Why?
|
| Leptin | 1 | 2016 | 1597 | 0.070 |
Why?
|
| Pregnancy Complications, Parasitic | 2 | 2005 | 61 | 0.070 |
Why?
|
| Thrombophilia | 1 | 2010 | 305 | 0.070 |
Why?
|
| Betaine-Homocysteine S-Methyltransferase | 1 | 2007 | 6 | 0.070 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2007 | 12 | 0.070 |
Why?
|
| Diabetes Mellitus | 3 | 2012 | 5841 | 0.070 |
Why?
|
| Receptors, Interleukin | 1 | 2008 | 243 | 0.070 |
Why?
|
| Uterus | 2 | 2021 | 649 | 0.070 |
Why?
|
| Chi-Square Distribution | 3 | 2008 | 3415 | 0.070 |
Why?
|
| Galectin 2 | 1 | 2007 | 13 | 0.070 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2001 | 396 | 0.070 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 5337 | 0.070 |
Why?
|
| Steroids | 2 | 2010 | 929 | 0.070 |
Why?
|
| Telomere-Binding Proteins | 2 | 2018 | 119 | 0.070 |
Why?
|
| Smoking Cessation | 3 | 2015 | 2057 | 0.070 |
Why?
|
| Life Expectancy | 1 | 2014 | 1243 | 0.070 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2008 | 225 | 0.070 |
Why?
|
| Gene Regulatory Networks | 4 | 2020 | 1745 | 0.070 |
Why?
|
| Infant | 14 | 2017 | 36193 | 0.070 |
Why?
|
| Cocarcinogenesis | 2 | 2004 | 49 | 0.070 |
Why?
|
| Joints | 1 | 2009 | 322 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2017 | 4001 | 0.070 |
Why?
|
| Choroidal Neovascularization | 1 | 2010 | 363 | 0.070 |
Why?
|
| Lymphotoxin-alpha | 1 | 2007 | 93 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2016 | 367 | 0.070 |
Why?
|
| Vaccination | 1 | 2019 | 3384 | 0.070 |
Why?
|
| Cerebrovascular Disorders | 3 | 1997 | 1474 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 867 | 0.070 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 5799 | 0.070 |
Why?
|
| Spain | 3 | 2010 | 487 | 0.070 |
Why?
|
| Predictive Value of Tests | 10 | 2015 | 15266 | 0.070 |
Why?
|
| Parturition | 1 | 2010 | 448 | 0.070 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2007 | 113 | 0.070 |
Why?
|
| Testosterone | 3 | 2015 | 2472 | 0.070 |
Why?
|
| Models, Biological | 3 | 2015 | 9469 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2015 | 2872 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2015 | 1136 | 0.070 |
Why?
|
| Health Occupations | 1 | 2008 | 222 | 0.070 |
Why?
|
| Tibia | 2 | 2010 | 1070 | 0.070 |
Why?
|
| Analysis of Variance | 5 | 2014 | 6228 | 0.070 |
Why?
|
| Mothers | 3 | 2007 | 2198 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2004 | 767 | 0.070 |
Why?
|
| Circadian Rhythm | 2 | 2012 | 2576 | 0.070 |
Why?
|
| Exons | 4 | 2009 | 2391 | 0.070 |
Why?
|
| Diet, Reducing | 2 | 2024 | 485 | 0.070 |
Why?
|
| Genomic Imprinting | 3 | 2017 | 329 | 0.070 |
Why?
|
| DNA Mutational Analysis | 3 | 2019 | 4111 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 3 | 2009 | 1601 | 0.070 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1985 | 69 | 0.070 |
Why?
|
| Contrast Media | 2 | 2017 | 5307 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 393 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 1994 | 507 | 0.070 |
Why?
|
| Apolipoproteins A | 1 | 2006 | 95 | 0.070 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2010 | 376 | 0.070 |
Why?
|
| Intrauterine Devices | 3 | 1998 | 113 | 0.070 |
Why?
|
| High Mobility Group Proteins | 3 | 2015 | 177 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 4 | 2008 | 1702 | 0.060 |
Why?
|
| Gadolinium DTPA | 1 | 2009 | 823 | 0.060 |
Why?
|
| Sodium Channels | 1 | 2007 | 339 | 0.060 |
Why?
|
| Sterilization, Reproductive | 1 | 2005 | 24 | 0.060 |
Why?
|
| Immunity | 1 | 2012 | 996 | 0.060 |
Why?
|
| Rad51 Recombinase | 2 | 2018 | 189 | 0.060 |
Why?
|
| Hair Dyes | 2 | 1996 | 30 | 0.060 |
Why?
|
| Wasting Syndrome | 1 | 2006 | 99 | 0.060 |
Why?
|
| RNA, Viral | 3 | 2006 | 2846 | 0.060 |
Why?
|
| Information Services | 1 | 2007 | 236 | 0.060 |
Why?
|
| National Health Programs | 1 | 2009 | 440 | 0.060 |
Why?
|
| Rural Population | 2 | 1993 | 2287 | 0.060 |
Why?
|
| Infant, Low Birth Weight | 4 | 2005 | 870 | 0.060 |
Why?
|
| Color | 1 | 2006 | 299 | 0.060 |
Why?
|
| Social Support | 1 | 2015 | 2172 | 0.060 |
Why?
|
| Vesicular Transport Proteins | 1 | 2008 | 376 | 0.060 |
Why?
|
| Abortion, Habitual | 1 | 1985 | 61 | 0.060 |
Why?
|
| Health Behavior | 4 | 2013 | 2644 | 0.060 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 1502 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2009 | 1132 | 0.060 |
Why?
|
| Brassica | 1 | 2004 | 39 | 0.060 |
Why?
|
| CD4-CD8 Ratio | 1 | 2005 | 114 | 0.060 |
Why?
|
| Bone Remodeling | 1 | 2009 | 581 | 0.060 |
Why?
|
| Menorrhagia | 2 | 2003 | 59 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2024 | 64685 | 0.060 |
Why?
|
| RNA-Binding Proteins | 3 | 2023 | 1898 | 0.060 |
Why?
|
| Physicians | 2 | 2005 | 4591 | 0.060 |
Why?
|
| Parasitemia | 1 | 2005 | 165 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2016 | 1363 | 0.060 |
Why?
|
| Occupations | 2 | 2000 | 515 | 0.060 |
Why?
|
| Apolipoprotein A-I | 1 | 2006 | 299 | 0.060 |
Why?
|
| Nociceptors | 1 | 2009 | 461 | 0.060 |
Why?
|
| Environmental Pollutants | 3 | 2007 | 1277 | 0.060 |
Why?
|
| Nurse Clinicians | 1 | 2004 | 30 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2010 | 10766 | 0.060 |
Why?
|
| Carcinogens, Environmental | 1 | 2005 | 72 | 0.060 |
Why?
|
| Mountaineering | 1 | 1984 | 45 | 0.060 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2004 | 17 | 0.060 |
Why?
|
| Peroxidase | 1 | 2008 | 609 | 0.060 |
Why?
|
| Fertility | 2 | 2021 | 771 | 0.060 |
Why?
|
| Acetaminophen | 1 | 2009 | 555 | 0.060 |
Why?
|
| Genes, p53 | 1 | 2007 | 712 | 0.060 |
Why?
|
| Fetal Growth Retardation | 1 | 1988 | 580 | 0.060 |
Why?
|
| Bone Neoplasms | 2 | 2015 | 2529 | 0.060 |
Why?
|
| Genes, APC | 1 | 2005 | 145 | 0.060 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2003 | 46 | 0.060 |
Why?
|
| Glycemic Index | 2 | 2004 | 396 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 2894 | 0.060 |
Why?
|
| Iron, Dietary | 1 | 2005 | 148 | 0.060 |
Why?
|
| Students | 2 | 1992 | 1741 | 0.060 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2004 | 29 | 0.060 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2007 | 352 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2024 | 64 | 0.060 |
Why?
|
| Homeostasis | 1 | 2015 | 3323 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 3 | 2009 | 56 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2024 | 1252 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 4514 | 0.060 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2011 | 926 | 0.060 |
Why?
|
| Progestins | 3 | 1997 | 301 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2001 | 1804 | 0.060 |
Why?
|
| Menstruation Disturbances | 1 | 2005 | 143 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2002 | 819 | 0.060 |
Why?
|
| Growth Hormone | 1 | 2006 | 569 | 0.060 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2004 | 82 | 0.060 |
Why?
|
| Altitude Sickness | 1 | 1984 | 91 | 0.060 |
Why?
|
| Gout Suppressants | 1 | 2005 | 177 | 0.060 |
Why?
|
| Endometrium | 2 | 2004 | 403 | 0.060 |
Why?
|
| Registries | 6 | 2014 | 8225 | 0.060 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 1463 | 0.060 |
Why?
|
| Allergens | 1 | 2011 | 1432 | 0.060 |
Why?
|
| Thymidylate Synthase | 1 | 2003 | 74 | 0.060 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2024 | 153 | 0.060 |
Why?
|
| Interleukins | 1 | 2008 | 782 | 0.060 |
Why?
|
| Ovulation | 2 | 2002 | 181 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 6131 | 0.060 |
Why?
|
| Choice Behavior | 2 | 2001 | 825 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2023 | 2898 | 0.050 |
Why?
|
| Ataxia Telangiectasia | 1 | 2004 | 107 | 0.050 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2009 | 1148 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1222 | 0.050 |
Why?
|
| North Carolina | 1 | 2024 | 325 | 0.050 |
Why?
|
| Child Mortality | 1 | 2005 | 205 | 0.050 |
Why?
|
| Microarray Analysis | 2 | 2017 | 750 | 0.050 |
Why?
|
| Mitomycin | 1 | 2004 | 263 | 0.050 |
Why?
|
| China | 2 | 2024 | 2374 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2018 | 1115 | 0.050 |
Why?
|
| Prolactin | 2 | 1995 | 625 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2005 | 486 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2244 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 705 | 0.050 |
Why?
|
| Telemedicine | 1 | 2020 | 3052 | 0.050 |
Why?
|
| Hysteroscopy | 1 | 2003 | 62 | 0.050 |
Why?
|
| France | 1 | 2024 | 497 | 0.050 |
Why?
|
| Binding Sites | 3 | 2017 | 6056 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1997 | 3206 | 0.050 |
Why?
|
| Hair | 1 | 2006 | 498 | 0.050 |
Why?
|
| DNA, Viral | 3 | 2006 | 2202 | 0.050 |
Why?
|
| Diarrhea | 3 | 2005 | 1318 | 0.050 |
Why?
|
| Steroid Hydroxylases | 2 | 2013 | 93 | 0.050 |
Why?
|
| Parvoviridae Infections | 1 | 2002 | 36 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2009 | 1139 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2016 | 2781 | 0.050 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2002 | 27 | 0.050 |
Why?
|
| Molecular Sequence Data | 6 | 2007 | 17635 | 0.050 |
Why?
|
| Cattle | 2 | 1999 | 3849 | 0.050 |
Why?
|
| Social Class | 4 | 2006 | 2004 | 0.050 |
Why?
|
| Parvovirus B19, Human | 1 | 2002 | 40 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2010 | 2203 | 0.050 |
Why?
|
| MicroRNAs | 2 | 2018 | 3816 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 1964 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2024 | 362 | 0.050 |
Why?
|
| Antifibrinolytic Agents | 1 | 2006 | 292 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2018 | 4937 | 0.050 |
Why?
|
| Biological Evolution | 1 | 2008 | 1071 | 0.050 |
Why?
|
| Private Practice | 1 | 1983 | 153 | 0.050 |
Why?
|
| Palliative Care | 1 | 2017 | 3598 | 0.050 |
Why?
|
| Pharmacoepidemiology | 1 | 2006 | 350 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2007 | 1154 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 652 | 0.050 |
Why?
|
| Adipogenesis | 2 | 2015 | 368 | 0.050 |
Why?
|
| Hypogonadism | 1 | 2008 | 798 | 0.050 |
Why?
|
| Fibrocystic Breast Disease | 2 | 1999 | 103 | 0.050 |
Why?
|
| Early Detection of Cancer | 2 | 2018 | 3201 | 0.050 |
Why?
|
| Fossil Fuels | 1 | 2022 | 53 | 0.050 |
Why?
|
| Patient Compliance | 3 | 2016 | 2690 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 855 | 0.050 |
Why?
|
| Intestinal Mucosa | 2 | 2010 | 3032 | 0.050 |
Why?
|
| Phobic Disorders | 1 | 2004 | 439 | 0.050 |
Why?
|
| Oligomenorrhea | 1 | 2001 | 42 | 0.050 |
Why?
|
| Monoamine Oxidase | 1 | 2002 | 181 | 0.050 |
Why?
|
| Pregnancy Complications | 3 | 2005 | 2947 | 0.050 |
Why?
|
| World Health Organization | 2 | 2018 | 1322 | 0.050 |
Why?
|
| Colon | 1 | 2010 | 1792 | 0.050 |
Why?
|
| Health Services Accessibility | 2 | 2017 | 5440 | 0.050 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2001 | 85 | 0.050 |
Why?
|
| Pregnancy Complications, Hematologic | 2 | 1999 | 180 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2012 | 1393 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 7593 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 3810 | 0.050 |
Why?
|
| HIV Seronegativity | 2 | 2000 | 211 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1336 | 0.050 |
Why?
|
| Heart Rate | 1 | 2013 | 4195 | 0.050 |
Why?
|
| TATA Box | 1 | 2001 | 127 | 0.050 |
Why?
|
| DDT | 1 | 2001 | 32 | 0.050 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2008 | 224 | 0.050 |
Why?
|
| Urban Population | 3 | 2006 | 2036 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2009 | 9280 | 0.050 |
Why?
|
| Gene Dosage | 3 | 2010 | 1218 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 1612 | 0.050 |
Why?
|
| Contact Tracing | 2 | 2020 | 271 | 0.050 |
Why?
|
| Gait | 2 | 2024 | 814 | 0.050 |
Why?
|
| Vagina | 1 | 2006 | 838 | 0.050 |
Why?
|
| Malnutrition | 1 | 2007 | 645 | 0.050 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2001 | 157 | 0.050 |
Why?
|
| Curriculum | 1 | 2014 | 3743 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 1069 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2006 | 999 | 0.050 |
Why?
|
| Translocation, Genetic | 2 | 1986 | 1393 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 116 | 0.050 |
Why?
|
| Ontario | 1 | 2001 | 398 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2018 | 569 | 0.050 |
Why?
|
| Postprandial Period | 1 | 2022 | 315 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2007 | 1509 | 0.050 |
Why?
|
| Resource Allocation | 1 | 1983 | 350 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1626 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2003 | 330 | 0.050 |
Why?
|
| Ultrasonography | 4 | 2001 | 5971 | 0.050 |
Why?
|
| Recreation | 1 | 2001 | 125 | 0.050 |
Why?
|
| Prostatitis | 1 | 2001 | 102 | 0.050 |
Why?
|
| Melatonin | 2 | 2003 | 669 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2004 | 662 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2005 | 604 | 0.040 |
Why?
|
| Clavicle | 1 | 1983 | 224 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 676 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2002 | 462 | 0.040 |
Why?
|
| Bone Density Conservation Agents | 1 | 2008 | 795 | 0.040 |
Why?
|
| Parents | 1 | 2014 | 3563 | 0.040 |
Why?
|
| Twins, Dizygotic | 1 | 2001 | 236 | 0.040 |
Why?
|
| Nutrition Policy | 2 | 2002 | 471 | 0.040 |
Why?
|
| AIDS Serodiagnosis | 1 | 2001 | 220 | 0.040 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 1902 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1248 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 1899 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2015 | 504 | 0.040 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 329 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 2004 | 1606 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 4762 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 1992 | 3807 | 0.040 |
Why?
|
| Disclosure | 1 | 2006 | 748 | 0.040 |
Why?
|
| Bone Marrow | 2 | 2024 | 2911 | 0.040 |
Why?
|
| T-Box Domain Proteins | 2 | 2012 | 469 | 0.040 |
Why?
|
| Talc | 1 | 2000 | 48 | 0.040 |
Why?
|
| Pigmentation | 1 | 2020 | 144 | 0.040 |
Why?
|
| DNA Fingerprinting | 1 | 1999 | 114 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2007 | 1555 | 0.040 |
Why?
|
| Medication Errors | 1 | 2005 | 783 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2005 | 542 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2024 | 7391 | 0.040 |
Why?
|
| Axilla | 1 | 2022 | 624 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 1997 | 2155 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2020 | 102 | 0.040 |
Why?
|
| Transferrin | 2 | 2005 | 283 | 0.040 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2018 | 16 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 3449 | 0.040 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2010 | 102 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2001 | 470 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2010 | 540 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2020 | 147 | 0.040 |
Why?
|
| Community Health Services | 1 | 2024 | 656 | 0.040 |
Why?
|
| Colles' Fracture | 1 | 1998 | 11 | 0.040 |
Why?
|
| Guidelines as Topic | 2 | 2013 | 1386 | 0.040 |
Why?
|
| Seafood | 1 | 2002 | 393 | 0.040 |
Why?
|
| Orthopedic Procedures | 1 | 2009 | 1265 | 0.040 |
Why?
|
| Riboflavin | 2 | 2015 | 107 | 0.040 |
Why?
|
| Sleep | 1 | 2014 | 4768 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2005 | 1347 | 0.040 |
Why?
|
| Cystitis, Interstitial | 1 | 1999 | 66 | 0.040 |
Why?
|
| Osteomyelitis | 1 | 1983 | 407 | 0.040 |
Why?
|
| Fluoridation | 1 | 1998 | 29 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 4 | 1997 | 1625 | 0.040 |
Why?
|
| Papillomaviridae | 1 | 2005 | 1119 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1993 | 3415 | 0.040 |
Why?
|
| Social Justice | 1 | 1983 | 478 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2002 | 723 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2009 | 3551 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2009 | 2009 | 0.040 |
Why?
|
| Energy Metabolism | 3 | 2015 | 2882 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2014 | 3358 | 0.040 |
Why?
|
| Health Status | 2 | 2017 | 4077 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 2018 | 195 | 0.040 |
Why?
|
| Genes, env | 1 | 1998 | 95 | 0.040 |
Why?
|
| Trinucleotide Repeats | 2 | 2010 | 257 | 0.040 |
Why?
|
| Body Composition | 3 | 2010 | 2426 | 0.040 |
Why?
|
| Myocardium | 2 | 2008 | 4725 | 0.040 |
Why?
|
| Placebos | 3 | 2009 | 1667 | 0.040 |
Why?
|
| New South Wales | 1 | 2017 | 69 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1998 | 166 | 0.040 |
Why?
|
| Water Pollutants | 1 | 2017 | 24 | 0.040 |
Why?
|
| Contraceptive Devices, Female | 1 | 1998 | 40 | 0.040 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1998 | 153 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2009 | 1469 | 0.040 |
Why?
|
| Genetic Heterogeneity | 2 | 2012 | 732 | 0.040 |
Why?
|
| Radius | 1 | 2001 | 441 | 0.040 |
Why?
|
| Fluorides | 1 | 1998 | 134 | 0.040 |
Why?
|
| Causality | 2 | 2017 | 1242 | 0.040 |
Why?
|
| Buttocks | 1 | 1998 | 111 | 0.040 |
Why?
|
| Circadian Clocks | 1 | 2020 | 164 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2006 | 2932 | 0.040 |
Why?
|
| State Government | 1 | 2020 | 384 | 0.040 |
Why?
|
| Capsid Proteins | 1 | 2001 | 468 | 0.040 |
Why?
|
| Gestational Age | 4 | 2010 | 3577 | 0.040 |
Why?
|
| Poisons | 1 | 1997 | 38 | 0.040 |
Why?
|
| Soil Pollutants | 1 | 2017 | 73 | 0.040 |
Why?
|
| Ferritins | 2 | 2005 | 598 | 0.040 |
Why?
|
| Ulna Fractures | 1 | 1998 | 126 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2024 | 1722 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2001 | 756 | 0.040 |
Why?
|
| Glutamine | 1 | 2000 | 577 | 0.040 |
Why?
|
| Confidentiality | 1 | 2001 | 609 | 0.040 |
Why?
|
| Temperature | 2 | 2014 | 2226 | 0.040 |
Why?
|
| Drug Administration Schedule | 3 | 2013 | 4853 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 6484 | 0.040 |
Why?
|
| Malaria, Falciparum | 1 | 2005 | 1077 | 0.040 |
Why?
|
| Apoptosis | 2 | 2020 | 9490 | 0.040 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 1997 | 25 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2022 | 658 | 0.030 |
Why?
|
| Vaginal Discharge | 1 | 1997 | 25 | 0.030 |
Why?
|
| Urinary Bladder | 2 | 2014 | 1152 | 0.030 |
Why?
|
| Methylmercury Compounds | 1 | 1997 | 103 | 0.030 |
Why?
|
| Diabetes, Gestational | 2 | 1997 | 1248 | 0.030 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 1998 | 121 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2004 | 1186 | 0.030 |
Why?
|
| Femoral Neck Fractures | 1 | 1998 | 142 | 0.030 |
Why?
|
| Trans-Activators | 3 | 2015 | 2856 | 0.030 |
Why?
|
| New Hampshire | 2 | 2007 | 175 | 0.030 |
Why?
|
| Chickens | 1 | 1999 | 859 | 0.030 |
Why?
|
| Benchmarking | 1 | 2023 | 1045 | 0.030 |
Why?
|
| Lead | 1 | 2002 | 879 | 0.030 |
Why?
|
| Contraceptive Agents | 1 | 1998 | 144 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 1997 | 205 | 0.030 |
Why?
|
| Child Development | 2 | 2005 | 2306 | 0.030 |
Why?
|
| Cyclophilins | 1 | 2016 | 48 | 0.030 |
Why?
|
| Food Contamination | 1 | 1997 | 191 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 1988 | 1924 | 0.030 |
Why?
|
| Lead Poisoning | 1 | 1999 | 322 | 0.030 |
Why?
|
| tRNA Methyltransferases | 1 | 2016 | 52 | 0.030 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 1997 | 116 | 0.030 |
Why?
|
| Risk Reduction Behavior | 2 | 2016 | 1112 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2018 | 2986 | 0.030 |
Why?
|
| Asia | 1 | 2017 | 619 | 0.030 |
Why?
|
| Electromagnetic Fields | 1 | 1998 | 296 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 8002 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 2017 | 302 | 0.030 |
Why?
|
| Seasons | 2 | 2007 | 1520 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2017 | 241 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2022 | 1271 | 0.030 |
Why?
|
| Patient Satisfaction | 2 | 2005 | 3462 | 0.030 |
Why?
|
| Genomic Instability | 2 | 2010 | 709 | 0.030 |
Why?
|
| Government Agencies | 1 | 2016 | 160 | 0.030 |
Why?
|
| Microsatellite Instability | 2 | 2010 | 716 | 0.030 |
Why?
|
| Blood Volume | 1 | 1997 | 547 | 0.030 |
Why?
|
| Leisure Activities | 1 | 1997 | 308 | 0.030 |
Why?
|
| Light | 1 | 2001 | 1353 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 3204 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 1998 | 744 | 0.030 |
Why?
|
| Walking | 1 | 2022 | 1198 | 0.030 |
Why?
|
| Research Subjects | 1 | 1997 | 249 | 0.030 |
Why?
|
| Multiple Myeloma | 2 | 2009 | 5146 | 0.030 |
Why?
|
| Formaldehyde | 1 | 2017 | 358 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 2169 | 0.030 |
Why?
|
| Periodontium | 1 | 2015 | 97 | 0.030 |
Why?
|
| Retrospective Studies | 8 | 2024 | 80647 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 2001 | 831 | 0.030 |
Why?
|
| Conservation of Natural Resources | 1 | 2017 | 211 | 0.030 |
Why?
|
| Algorithms | 5 | 2018 | 14033 | 0.030 |
Why?
|
| Candidiasis | 1 | 1998 | 365 | 0.030 |
Why?
|
| SEER Program | 1 | 2000 | 1450 | 0.030 |
Why?
|
| Patient Advocacy | 1 | 1997 | 360 | 0.030 |
Why?
|
| Genome | 3 | 2011 | 1740 | 0.030 |
Why?
|
| Recurrence | 3 | 2014 | 8466 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1999 | 914 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 1756 | 0.030 |
Why?
|
| Pain, Postoperative | 2 | 2005 | 1740 | 0.030 |
Why?
|
| Adipocytes | 2 | 2015 | 1194 | 0.030 |
Why?
|
| Plant Oils | 1 | 1996 | 198 | 0.030 |
Why?
|
| Epithelium | 1 | 1999 | 1603 | 0.030 |
Why?
|
| Quality of Life | 5 | 2024 | 13367 | 0.030 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2014 | 46 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 290 | 0.030 |
Why?
|
| Atlases as Topic | 1 | 2016 | 248 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2010 | 10451 | 0.030 |
Why?
|
| History, Ancient | 1 | 2015 | 212 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2001 | 1255 | 0.030 |
Why?
|
| Spermatocidal Agents | 1 | 1994 | 15 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2015 | 164 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 58 | 0.030 |
Why?
|
| Syphilis Serodiagnosis | 1 | 1994 | 37 | 0.030 |
Why?
|
| Vaginal Smears | 2 | 1974 | 499 | 0.030 |
Why?
|
| Silicones | 1 | 1995 | 228 | 0.030 |
Why?
|
| Anovulation | 1 | 1994 | 54 | 0.030 |
Why?
|
| Motor Activity | 1 | 2004 | 2715 | 0.030 |
Why?
|
| Insulin Resistance | 3 | 2015 | 3964 | 0.030 |
Why?
|
| Self Disclosure | 1 | 1995 | 249 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2015 | 154 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 57 | 0.030 |
Why?
|
| England | 1 | 2015 | 526 | 0.030 |
Why?
|
| Alveolar Process | 1 | 2015 | 294 | 0.030 |
Why?
|
| Cell Survival | 1 | 2004 | 5791 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 720 | 0.030 |
Why?
|
| Stromal Cells | 1 | 1999 | 1330 | 0.030 |
Why?
|
| Growth | 1 | 1996 | 365 | 0.030 |
Why?
|
| Computer Simulation | 3 | 2017 | 6241 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 550 | 0.030 |
Why?
|
| Vaginal Neoplasms | 1 | 1974 | 104 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1997 | 1541 | 0.030 |
Why?
|
| Anorexia Nervosa | 2 | 1995 | 1361 | 0.030 |
Why?
|
| beta 2-Microglobulin | 1 | 1994 | 329 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 224 | 0.030 |
Why?
|
| Chlorine | 1 | 1993 | 57 | 0.030 |
Why?
|
| Longevity | 1 | 2021 | 1065 | 0.030 |
Why?
|
| Castration | 1 | 1973 | 151 | 0.030 |
Why?
|
| Sterilization, Tubal | 1 | 1993 | 75 | 0.030 |
Why?
|
| beta-Carotene 15,15'-Monooxygenase | 1 | 2013 | 12 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2017 | 638 | 0.030 |
Why?
|
| Bone and Bones | 2 | 2021 | 2568 | 0.030 |
Why?
|
| Hemoglobin A | 1 | 1993 | 84 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 3530 | 0.030 |
Why?
|
| Glucose | 2 | 2019 | 4347 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1994 | 294 | 0.030 |
Why?
|
| California | 1 | 1997 | 1430 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 12973 | 0.030 |
Why?
|
| Competency-Based Education | 1 | 2015 | 222 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 1996 | 329 | 0.030 |
Why?
|
| Isosorbide Dinitrate | 1 | 1993 | 34 | 0.030 |
Why?
|
| Heroin | 1 | 1993 | 119 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 842 | 0.030 |
Why?
|
| Sulfur | 1 | 1993 | 162 | 0.030 |
Why?
|
| Staff Development | 1 | 2015 | 228 | 0.030 |
Why?
|
| Glucose Tolerance Test | 2 | 2012 | 1178 | 0.030 |
Why?
|
| Mutagens | 1 | 2013 | 179 | 0.030 |
Why?
|
| Cholelithiasis | 1 | 1994 | 407 | 0.030 |
Why?
|
| Mouth | 1 | 2015 | 381 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 1998 | 1036 | 0.030 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 1993 | 155 | 0.030 |
Why?
|
| Radius Fractures | 1 | 1998 | 515 | 0.030 |
Why?
|
| Patient Participation | 1 | 2001 | 1445 | 0.030 |
Why?
|
| Prostate | 2 | 2011 | 1773 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 2319 | 0.030 |
Why?
|
| Phylogeny | 1 | 2000 | 2811 | 0.030 |
Why?
|
| Survival Rate | 3 | 2012 | 12723 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 2254 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 1995 | 285 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4576 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 318 | 0.020 |
Why?
|
| Fetal Death | 3 | 2005 | 435 | 0.020 |
Why?
|
| Colonoscopy | 3 | 2009 | 1394 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2004 | 2373 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2014 | 345 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2016 | 868 | 0.020 |
Why?
|
| Computer-Assisted Instruction | 1 | 2015 | 362 | 0.020 |
Why?
|
| Diet, Mediterranean | 1 | 2018 | 740 | 0.020 |
Why?
|
| Sweden | 2 | 2009 | 1379 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 223 | 0.020 |
Why?
|
| Point Mutation | 1 | 1997 | 1595 | 0.020 |
Why?
|
| Faculty | 1 | 2015 | 384 | 0.020 |
Why?
|
| Pakistan | 1 | 2012 | 293 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Contraceptive Devices, Male | 1 | 1991 | 13 | 0.020 |
Why?
|
| Liver | 3 | 2015 | 7528 | 0.020 |
Why?
|
| Family Health | 2 | 2009 | 1257 | 0.020 |
Why?
|
| Mice | 4 | 2024 | 81539 | 0.020 |
Why?
|
| DNA Primase | 1 | 2012 | 110 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2016 | 1968 | 0.020 |
Why?
|
| Problem-Based Learning | 1 | 2015 | 356 | 0.020 |
Why?
|
| Survivors | 1 | 2022 | 2371 | 0.020 |
Why?
|
| Breast Implants | 1 | 1995 | 411 | 0.020 |
Why?
|
| Work | 1 | 2012 | 195 | 0.020 |
Why?
|
| Laminin | 1 | 2012 | 408 | 0.020 |
Why?
|
| Methadone | 1 | 1993 | 321 | 0.020 |
Why?
|
| Organizational Culture | 1 | 2015 | 509 | 0.020 |
Why?
|
| Keratin-5 | 1 | 2010 | 45 | 0.020 |
Why?
|
| Private Sector | 1 | 1994 | 398 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1422 | 0.020 |
Why?
|
| Occupational Health | 1 | 2017 | 806 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 2915 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 4580 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2005 | 3980 | 0.020 |
Why?
|
| Copper | 1 | 1993 | 369 | 0.020 |
Why?
|
| Mercury | 1 | 1993 | 290 | 0.020 |
Why?
|
| Religion | 1 | 2014 | 372 | 0.020 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2005 | 461 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2024 | 3242 | 0.020 |
Why?
|
| Pre-Eclampsia | 2 | 1999 | 1231 | 0.020 |
Why?
|
| Dogs | 2 | 1993 | 3839 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 192 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 602 | 0.020 |
Why?
|
| Vitamin E Deficiency | 1 | 2010 | 30 | 0.020 |
Why?
|
| Africa | 1 | 1993 | 709 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2006 | 3627 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Ventricular Function | 1 | 1992 | 406 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 701 | 0.020 |
Why?
|
| Cyprus | 1 | 2010 | 96 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2012 | 882 | 0.020 |
Why?
|
| HIV Core Protein p24 | 2 | 2001 | 245 | 0.020 |
Why?
|
| Glycosyltransferases | 1 | 2010 | 116 | 0.020 |
Why?
|
| Hip Fractures | 1 | 1998 | 988 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2018 | 8633 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 115 | 0.020 |
Why?
|
| Magnesium | 1 | 1993 | 804 | 0.020 |
Why?
|
| Vitamin A Deficiency | 1 | 2010 | 88 | 0.020 |
Why?
|
| Sulfites | 1 | 2010 | 83 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2003 | 2751 | 0.020 |
Why?
|
| Agouti Signaling Protein | 1 | 2009 | 23 | 0.020 |
Why?
|
| Caspase 10 | 1 | 2009 | 3 | 0.020 |
Why?
|
| Soil | 1 | 1990 | 115 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2013 | 718 | 0.020 |
Why?
|
| Patient Selection | 1 | 2001 | 4244 | 0.020 |
Why?
|
| Health Planning Technical Assistance | 1 | 2009 | 5 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 2015 | 532 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2010 | 190 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 1992 | 590 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2010 | 174 | 0.020 |
Why?
|
| Chromosome Banding | 2 | 1986 | 260 | 0.020 |
Why?
|
| Blood Sedimentation | 1 | 2010 | 235 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2015 | 1341 | 0.020 |
Why?
|
| Maternal Age | 3 | 1997 | 809 | 0.020 |
Why?
|
| Acute Disease | 2 | 1994 | 7237 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 799 | 0.020 |
Why?
|
| Metabolome | 1 | 2016 | 989 | 0.020 |
Why?
|
| Health Transition | 1 | 2009 | 35 | 0.020 |
Why?
|
| Lipids | 1 | 2020 | 3341 | 0.020 |
Why?
|
| Community Health Centers | 1 | 1993 | 461 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2015 | 1176 | 0.020 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2009 | 74 | 0.020 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2009 | 88 | 0.020 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2009 | 77 | 0.020 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1993 | 529 | 0.020 |
Why?
|
| Fetal Distress | 1 | 1988 | 39 | 0.020 |
Why?
|
| Affective Disorders, Psychotic | 1 | 1990 | 186 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2011 | 220 | 0.020 |
Why?
|
| Proprotein Convertases | 1 | 2009 | 95 | 0.020 |
Why?
|
| Swine | 1 | 1999 | 5915 | 0.020 |
Why?
|
| Prenatal Diagnosis | 2 | 1988 | 1265 | 0.020 |
Why?
|
| RNA | 1 | 2018 | 2725 | 0.020 |
Why?
|
| Hawaii | 1 | 2008 | 102 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 1998 | 1749 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 489 | 0.020 |
Why?
|
| Osteoporosis | 1 | 1998 | 1606 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2009 | 266 | 0.020 |
Why?
|
| Anti-HIV Agents | 2 | 2009 | 4527 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 6534 | 0.020 |
Why?
|
| Schizophrenic Psychology | 1 | 1995 | 1647 | 0.020 |
Why?
|
| Family | 3 | 2010 | 3195 | 0.020 |
Why?
|
| Interleukin-16 | 1 | 2008 | 34 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3094 | 0.020 |
Why?
|
| Middle East | 1 | 2009 | 231 | 0.020 |
Why?
|
| Cholesterol, Dietary | 1 | 2008 | 224 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 506 | 0.020 |
Why?
|
| United Nations | 1 | 2009 | 150 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2008 | 2691 | 0.020 |
Why?
|
| Camptothecin | 1 | 2012 | 591 | 0.020 |
Why?
|
| Oxytocin | 1 | 1992 | 402 | 0.020 |
Why?
|
| Equipment Design | 1 | 2016 | 3511 | 0.020 |
Why?
|
| Taq Polymerase | 1 | 2007 | 20 | 0.020 |
Why?
|
| Life Change Events | 1 | 1993 | 952 | 0.020 |
Why?
|
| Los Angeles | 1 | 2008 | 243 | 0.020 |
Why?
|
| Organizations | 1 | 2009 | 171 | 0.020 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2007 | 72 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2009 | 425 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22174 | 0.020 |
Why?
|
| Interinstitutional Relations | 1 | 2009 | 236 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 1574 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1349 | 0.020 |
Why?
|
| Relief Work | 1 | 2009 | 131 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Random Allocation | 3 | 1998 | 2395 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1993 | 851 | 0.020 |
Why?
|
| Asia, Southeastern | 1 | 2007 | 114 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2979 | 0.020 |
Why?
|
| Japan | 1 | 2011 | 1378 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2011 | 899 | 0.020 |
Why?
|
| Infant, Premature | 2 | 2005 | 2107 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2008 | 257 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2008 | 265 | 0.020 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2007 | 141 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2009 | 426 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1999 | 5112 | 0.020 |
Why?
|
| Boston | 3 | 2003 | 9327 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 1712 | 0.020 |
Why?
|
| Chromatin | 1 | 2018 | 2961 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 502 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 1988 | 378 | 0.020 |
Why?
|
| Carbonated Beverages | 1 | 2007 | 210 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 629 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 16990 | 0.020 |
Why?
|
| Leukemia | 1 | 1994 | 1522 | 0.020 |
Why?
|
| Virus Shedding | 1 | 2006 | 111 | 0.020 |
Why?
|
| DNA Replication | 2 | 2007 | 1418 | 0.020 |
Why?
|
| Adipokines | 1 | 2008 | 310 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 1835 | 0.020 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 329 | 0.020 |
Why?
|
| Arthrography | 1 | 2007 | 150 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2009 | 750 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 1996 | 1813 | 0.020 |
Why?
|
| MEDLINE | 1 | 2006 | 119 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2017 | 1853 | 0.020 |
Why?
|
| Poverty | 1 | 2017 | 2697 | 0.020 |
Why?
|
| Scotland | 2 | 1995 | 143 | 0.020 |
Why?
|
| Histones | 1 | 2016 | 2580 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1405 | 0.020 |
Why?
|
| Public Health Nursing | 1 | 2005 | 14 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3639 | 0.020 |
Why?
|
| Leadership | 1 | 2015 | 1385 | 0.020 |
Why?
|
| Science | 1 | 2008 | 239 | 0.020 |
Why?
|
| Lymphoma | 1 | 1994 | 1901 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 1769 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 662 | 0.020 |
Why?
|
| Mitochondria | 1 | 2018 | 3624 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2014 | 7968 | 0.010 |
Why?
|
| Androstenedione | 1 | 2004 | 131 | 0.010 |
Why?
|
| Pharmacogenetics | 1 | 2009 | 675 | 0.010 |
Why?
|
| Food | 1 | 1989 | 774 | 0.010 |
Why?
|
| Fetus | 2 | 2002 | 1863 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2015 | 3025 | 0.010 |
Why?
|
| Oxygen Consumption | 2 | 1984 | 1866 | 0.010 |
Why?
|
| Neopterin | 2 | 1994 | 56 | 0.010 |
Why?
|
| Acetazolamide | 1 | 1984 | 96 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2013 | 4125 | 0.010 |
Why?
|
| Estrogens, Catechol | 1 | 2004 | 25 | 0.010 |
Why?
|
| Acclimatization | 1 | 1984 | 113 | 0.010 |
Why?
|
| Food Supply | 1 | 1990 | 544 | 0.010 |
Why?
|
| Glucuronides | 1 | 2004 | 20 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 215 | 0.010 |
Why?
|
| Efficiency, Organizational | 1 | 2009 | 695 | 0.010 |
Why?
|
| Muscular Dystrophies | 1 | 1986 | 390 | 0.010 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2004 | 68 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2490 | 0.010 |
Why?
|
| Allopurinol | 1 | 2005 | 198 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1640 | 0.010 |
Why?
|
| Peer Review, Research | 1 | 2007 | 340 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3088 | 0.010 |
Why?
|
| Fasting | 1 | 2010 | 1603 | 0.010 |
Why?
|
| Hemochromatosis | 1 | 2005 | 174 | 0.010 |
Why?
|
| Blood Donors | 1 | 1986 | 345 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2007 | 1991 | 0.010 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 1866 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 2005 | 291 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2004 | 186 | 0.010 |
Why?
|
| Nepal | 1 | 1984 | 305 | 0.010 |
Why?
|
| Heterosexuality | 1 | 2006 | 309 | 0.010 |
Why?
|
| Memory | 1 | 1993 | 2193 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2009 | 970 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2006 | 623 | 0.010 |
Why?
|
| Air Pollutants | 1 | 2017 | 2896 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2050 | 0.010 |
Why?
|
| ras Proteins | 1 | 2008 | 1054 | 0.010 |
Why?
|
| Survival | 1 | 2003 | 161 | 0.010 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2003 | 53 | 0.010 |
Why?
|
| Cordocentesis | 1 | 2002 | 10 | 0.010 |
Why?
|
| Solar System | 1 | 2002 | 12 | 0.010 |
Why?
|
| Cadherins | 1 | 2008 | 903 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8321 | 0.010 |
Why?
|
| Wisconsin | 1 | 2002 | 122 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2005 | 605 | 0.010 |
Why?
|
| Verbal Learning | 1 | 2005 | 463 | 0.010 |
Why?
|
| Antimalarials | 1 | 2009 | 907 | 0.010 |
Why?
|
| Administration, Oral | 2 | 2005 | 4021 | 0.010 |
Why?
|
| Stem Cells | 1 | 2015 | 3524 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 2005 | 367 | 0.010 |
Why?
|
| Beer | 1 | 2002 | 134 | 0.010 |
Why?
|
| Politics | 1 | 2009 | 815 | 0.010 |
Why?
|
| Secretory Rate | 1 | 2001 | 81 | 0.010 |
Why?
|
| Hydrops Fetalis | 1 | 2002 | 113 | 0.010 |
Why?
|
| Pelvic Pain | 1 | 2004 | 298 | 0.010 |
Why?
|
| Nursing Research | 1 | 2002 | 80 | 0.010 |
Why?
|
| Wine | 1 | 2002 | 166 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8833 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2020 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1984 | 409 | 0.010 |
Why?
|
| Parasitic Diseases | 1 | 2001 | 76 | 0.010 |
Why?
|
| Emotions | 1 | 2013 | 2739 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2004 | 1019 | 0.010 |
Why?
|
| Pregnancy Rate | 1 | 2004 | 648 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2015 | 2332 | 0.010 |
Why?
|
| Maternal Welfare | 1 | 2001 | 112 | 0.010 |
Why?
|
| Middle Cerebral Artery | 1 | 2002 | 275 | 0.010 |
Why?
|
| Disease Notification | 1 | 2001 | 95 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 2004 | 635 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2009 | 1897 | 0.010 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2005 | 464 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 1745 | 0.010 |
Why?
|
| Pineal Gland | 1 | 2001 | 158 | 0.010 |
Why?
|
| Gases | 1 | 2001 | 204 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3733 | 0.010 |
Why?
|
| Brain | 2 | 2023 | 27121 | 0.010 |
Why?
|
| Systole | 1 | 2002 | 936 | 0.010 |
Why?
|
| Brain Edema | 1 | 1984 | 604 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 2001 | 312 | 0.010 |
Why?
|
| Peritoneum | 1 | 2001 | 225 | 0.010 |
Why?
|
| Physical Fitness | 1 | 1984 | 743 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 2001 | 272 | 0.010 |
Why?
|
| Daucus carota | 1 | 1999 | 10 | 0.010 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2002 | 583 | 0.010 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 206 | 0.010 |
Why?
|
| Gene Products, env | 1 | 2001 | 250 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2002 | 731 | 0.010 |
Why?
|
| Methyltransferases | 1 | 2003 | 377 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1988 | 1398 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2004 | 1791 | 0.010 |
Why?
|
| Amenorrhea | 1 | 2003 | 483 | 0.010 |
Why?
|
| Lighting | 1 | 2001 | 211 | 0.010 |
Why?
|
| Anti-Retroviral Agents | 1 | 2009 | 1784 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2005 | 1188 | 0.010 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 1177 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 1986 | 1303 | 0.010 |
Why?
|
| Software | 1 | 2013 | 4434 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2448 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2002 | 1371 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1983 | 1972 | 0.010 |
Why?
|
| Body Burden | 1 | 1999 | 158 | 0.010 |
Why?
|
| Perineum | 1 | 2000 | 208 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2010 | 3677 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2009 | 2884 | 0.010 |
Why?
|
| Memory, Short-Term | 1 | 2005 | 982 | 0.010 |
Why?
|
| Rectal Neoplasms | 2 | 1999 | 1157 | 0.010 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 1998 | 59 | 0.010 |
Why?
|
| Forearm Injuries | 1 | 1998 | 68 | 0.010 |
Why?
|
| Capsid | 1 | 2001 | 435 | 0.010 |
Why?
|
| Pyridoxine | 1 | 1998 | 108 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 3492 | 0.010 |
Why?
|
| Lymphatic Diseases | 1 | 1980 | 320 | 0.010 |
Why?
|
| Pedigree | 1 | 1985 | 4542 | 0.010 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1978 | 308 | 0.010 |
Why?
|
| Biological Availability | 1 | 1998 | 390 | 0.010 |
Why?
|
| Arsenic Poisoning | 1 | 1997 | 55 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2005 | 1010 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2001 | 793 | 0.010 |
Why?
|
| Dopamine | 1 | 2004 | 1607 | 0.010 |
Why?
|
| Nutritive Value | 1 | 2000 | 350 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 5439 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 3359 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2003 | 1469 | 0.010 |
Why?
|
| Tetrahydrofolates | 1 | 1997 | 58 | 0.010 |
Why?
|
| Schizophrenia | 1 | 1995 | 6937 | 0.010 |
Why?
|
| Diphosphoglyceric Acids | 1 | 1976 | 31 | 0.010 |
Why?
|
| Analgesia | 1 | 2001 | 461 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11076 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2002 | 2048 | 0.010 |
Why?
|
| Biometry | 1 | 1999 | 563 | 0.010 |
Why?
|
| Nutrition Assessment | 1 | 1999 | 728 | 0.010 |
Why?
|
| Bone Diseases, Metabolic | 1 | 1999 | 409 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5305 | 0.010 |
Why?
|
| Romania | 1 | 1994 | 92 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1982 | 1182 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 2003 | 4544 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 1998 | 561 | 0.010 |
Why?
|
| Immunity, Active | 1 | 1993 | 58 | 0.010 |
Why?
|
| Death Certificates | 1 | 1994 | 167 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1978 | 1682 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1997 | 1152 | 0.010 |
Why?
|
| Prefrontal Cortex | 1 | 2004 | 2220 | 0.010 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 1995 | 276 | 0.010 |
Why?
|
| Abdomen | 1 | 1999 | 1128 | 0.010 |
Why?
|
| Contraceptive Agents, Female | 1 | 1995 | 118 | 0.010 |
Why?
|
| Counseling | 1 | 2001 | 1547 | 0.010 |
Why?
|
| Sigmoidoscopy | 1 | 1994 | 151 | 0.010 |
Why?
|
| Macrophages | 1 | 2008 | 5767 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 1999 | 1738 | 0.010 |
Why?
|
| Premature Birth | 1 | 2005 | 1782 | 0.010 |
Why?
|
| Electric Injuries | 1 | 1993 | 24 | 0.010 |
Why?
|
| Kidney | 1 | 1988 | 7048 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1973 | 861 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 1994 | 504 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 18966 | 0.010 |
Why?
|
| Asthma | 1 | 2011 | 6234 | 0.010 |
Why?
|
| Community Mental Health Services | 1 | 1995 | 392 | 0.010 |
Why?
|
| Sex Education | 1 | 1992 | 94 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2005 | 7054 | 0.010 |
Why?
|
| Narcotics | 1 | 1993 | 336 | 0.010 |
Why?
|
| Body Temperature | 1 | 1974 | 781 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1973 | 726 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 1998 | 907 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1973 | 820 | 0.010 |
Why?
|
| Health Expenditures | 1 | 1983 | 2366 | 0.010 |
Why?
|
| Birth Order | 1 | 1990 | 95 | 0.010 |
Why?
|
| Cell Division | 1 | 1997 | 4465 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1994 | 1173 | 0.010 |
Why?
|
| Hepatitis B | 1 | 1994 | 705 | 0.000 |
Why?
|
| Marriage | 1 | 1990 | 351 | 0.000 |
Why?
|
| Postoperative Care | 1 | 1974 | 1468 | 0.000 |
Why?
|
| Cluster Analysis | 1 | 1994 | 2707 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 13446 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1976 | 2413 | 0.000 |
Why?
|
| Decision Making | 1 | 1979 | 3929 | 0.000 |
Why?
|
| Exercise Test | 1 | 1993 | 2127 | 0.000 |
Why?
|
| Biopsy | 1 | 1997 | 6766 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1986 | 1302 | 0.000 |
Why?
|
| Social Environment | 1 | 1990 | 1020 | 0.000 |
Why?
|
| X Chromosome | 1 | 1986 | 816 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 1995 | 3600 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1993 | 4160 | 0.000 |
Why?
|
| Cyclothymic Disorder | 1 | 1982 | 42 | 0.000 |
Why?
|
| Coronary Angiography | 1 | 1993 | 4471 | 0.000 |
Why?
|
| Syndrome | 1 | 1986 | 3267 | 0.000 |
Why?
|
| Platelet Count | 1 | 1982 | 781 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1993 | 6377 | 0.000 |
Why?
|
| Closing Volume | 1 | 1978 | 3 | 0.000 |
Why?
|
| Maximal Expiratory Flow-Volume Curves | 1 | 1978 | 25 | 0.000 |
Why?
|
| Residual Volume | 1 | 1978 | 41 | 0.000 |
Why?
|
| Functional Residual Capacity | 1 | 1978 | 70 | 0.000 |
Why?
|
| Partial Pressure | 1 | 1978 | 245 | 0.000 |
Why?
|
| Pharyngeal Diseases | 1 | 1980 | 134 | 0.000 |
Why?
|
| Total Lung Capacity | 1 | 1978 | 149 | 0.000 |
Why?
|
| Nitrogen | 1 | 1978 | 348 | 0.000 |
Why?
|
| Personality Disorders | 1 | 1982 | 722 | 0.000 |
Why?
|
| Leg | 1 | 1982 | 1088 | 0.000 |
Why?
|
| Vital Capacity | 1 | 1978 | 971 | 0.000 |
Why?
|
| Hospitalization | 1 | 1995 | 10721 | 0.000 |
Why?
|
| Spirometry | 1 | 1978 | 929 | 0.000 |
Why?
|
| Neck | 1 | 1980 | 734 | 0.000 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1976 | 461 | 0.000 |
Why?
|
| Forced Expiratory Volume | 1 | 1978 | 1814 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1973 | 15633 | 0.000 |
Why?
|
| Depressive Disorder | 1 | 1982 | 3728 | 0.000 |
Why?
|
| Oxygen | 1 | 1978 | 4227 | 0.000 |
Why?
|
| Bipolar Disorder | 1 | 1982 | 5092 | 0.000 |
Why?
|